NO820355L - PROCEDURES FOR THE PREPARATION OF CYCLIC AMINOPHENYL ETHER COMPOUNDS. - Google Patents
PROCEDURES FOR THE PREPARATION OF CYCLIC AMINOPHENYL ETHER COMPOUNDS.Info
- Publication number
- NO820355L NO820355L NO820355A NO820355A NO820355L NO 820355 L NO820355 L NO 820355L NO 820355 A NO820355 A NO 820355A NO 820355 A NO820355 A NO 820355A NO 820355 L NO820355 L NO 820355L
- Authority
- NO
- Norway
- Prior art keywords
- menthan
- yloxy
- found
- calculated
- elemental analysis
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 37
- 238000002360 preparation method Methods 0.000 title claims description 3
- GOJFAKBEASOYNM-UHFFFAOYSA-N 2-(2-aminophenoxy)aniline Chemical class NC1=CC=CC=C1OC1=CC=CC=C1N GOJFAKBEASOYNM-UHFFFAOYSA-N 0.000 title description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 128
- -1 cyclic aminophenyl- ether compound Chemical class 0.000 claims description 69
- 150000001875 compounds Chemical class 0.000 claims description 57
- 125000000217 alkyl group Chemical group 0.000 claims description 20
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 12
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 138
- 238000000921 elemental analysis Methods 0.000 description 68
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 60
- 238000002844 melting Methods 0.000 description 60
- 230000008018 melting Effects 0.000 description 60
- 239000000203 mixture Substances 0.000 description 54
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 53
- 239000000243 solution Substances 0.000 description 42
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 39
- 239000007858 starting material Substances 0.000 description 37
- 239000000047 product Substances 0.000 description 34
- 239000002904 solvent Substances 0.000 description 34
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical compound CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 description 32
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 32
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 239000013078 crystal Substances 0.000 description 29
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 27
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 26
- 238000001816 cooling Methods 0.000 description 22
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 18
- 239000011541 reaction mixture Substances 0.000 description 18
- 238000003756 stirring Methods 0.000 description 18
- 229960001413 acetanilide Drugs 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 16
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- 238000009835 boiling Methods 0.000 description 15
- 235000012000 cholesterol Nutrition 0.000 description 15
- 201000004624 Dermatitis Diseases 0.000 description 13
- 208000010668 atopic eczema Diseases 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000011780 sodium chloride Substances 0.000 description 13
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- 108010010234 HDL Lipoproteins Proteins 0.000 description 12
- 102000015779 HDL Lipoproteins Human genes 0.000 description 12
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical group C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 238000010992 reflux Methods 0.000 description 11
- 239000000741 silica gel Substances 0.000 description 11
- 229910002027 silica gel Inorganic materials 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- UODXCYZDMHPIJE-UHFFFAOYSA-N menthanol Chemical compound CC1CCC(C(C)(C)O)CC1 UODXCYZDMHPIJE-UHFFFAOYSA-N 0.000 description 9
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 9
- ARKJTWNPSFJACO-UHFFFAOYSA-N 4-[2-(4-methylcyclohexyl)propan-2-yloxy]aniline Chemical compound C1CC(C)CCC1C(C)(C)OC1=CC=C(N)C=C1 ARKJTWNPSFJACO-UHFFFAOYSA-N 0.000 description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 229910000027 potassium carbonate Inorganic materials 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 229910052740 iodine Inorganic materials 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 5
- 206010003210 Arteriosclerosis Diseases 0.000 description 5
- KBNLYNNKZZJEGQ-SHTZXODSSA-N C(C)OC(=O)NC1=CC=C(C=C1)OC([C@@H]1CC[C@H](CC1)C)(C)C Chemical compound C(C)OC(=O)NC1=CC=C(C=C1)OC([C@@H]1CC[C@H](CC1)C)(C)C KBNLYNNKZZJEGQ-SHTZXODSSA-N 0.000 description 5
- 208000011775 arteriosclerosis disease Diseases 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- IBODDUNKEPPBKW-UHFFFAOYSA-N 1,5-dibromopentane Chemical compound BrCCCCCBr IBODDUNKEPPBKW-UHFFFAOYSA-N 0.000 description 4
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- ARKJTWNPSFJACO-JOCQHMNTSA-N [C@H]1(CC[C@H](CC1)C(C)(C)OC1=CC=C(N)C=C1)C Chemical compound [C@H]1(CC[C@H](CC1)C(C)(C)OC1=CC=C(N)C=C1)C ARKJTWNPSFJACO-JOCQHMNTSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 150000001448 anilines Chemical class 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 150000001555 benzenes Chemical class 0.000 description 4
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 4
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 4
- 239000012280 lithium aluminium hydride Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- HVXJILXIZHJUAE-UHFFFAOYSA-N 1-[4-[2-(4-methylcyclohexyl)propan-2-yloxy]phenyl]piperidine Chemical compound C1CC(C)CCC1C(C)(C)OC1=CC=C(N2CCCCC2)C=C1 HVXJILXIZHJUAE-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- IJXGDXZOHDXPKK-UHFFFAOYSA-N N-[4-[2-(4-methylcyclohexyl)propan-2-yloxy]phenyl]octadecanamide Chemical compound C1(CCC(CC1)C(C)(C)OC1=CC=C(NC(CCCCCCCCCCCCCCCCC)=O)C=C1)C IJXGDXZOHDXPKK-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- VSSAZBXXNIABDN-UHFFFAOYSA-N cyclohexylmethanol Chemical compound OCC1CCCCC1 VSSAZBXXNIABDN-UHFFFAOYSA-N 0.000 description 3
- IPIVAXLHTVNRBS-UHFFFAOYSA-N decanoyl chloride Chemical compound CCCCCCCCCC(Cl)=O IPIVAXLHTVNRBS-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 230000000069 prophylactic effect Effects 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- DTSZTPPMUGNHKT-UHFFFAOYSA-N 1,5-dimethyl-2-propan-2-ylcyclohexan-1-ol Chemical compound CC(C)C1CCC(C)CC1(C)O DTSZTPPMUGNHKT-UHFFFAOYSA-N 0.000 description 2
- HNTGIJLWHDPAFN-UHFFFAOYSA-N 1-bromohexadecane Chemical compound CCCCCCCCCCCCCCCCBr HNTGIJLWHDPAFN-UHFFFAOYSA-N 0.000 description 2
- JMSUNAQVHOHLMX-UHFFFAOYSA-N 1-cyclohexylethanol Chemical compound CC(O)C1CCCCC1 JMSUNAQVHOHLMX-UHFFFAOYSA-N 0.000 description 2
- WFQDTOYDVUWQMS-UHFFFAOYSA-N 1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1 WFQDTOYDVUWQMS-UHFFFAOYSA-N 0.000 description 2
- HMXMWOXFKFLOGK-UHFFFAOYSA-N 2-(4-methylcyclohexen-1-yl)propan-2-ol Chemical compound CC1CCC(C(C)(C)O)=CC1 HMXMWOXFKFLOGK-UHFFFAOYSA-N 0.000 description 2
- SSZWOQANOUHNLV-UHFFFAOYSA-N 2-cyclohexylpropan-2-ol Chemical compound CC(C)(O)C1CCCCC1 SSZWOQANOUHNLV-UHFFFAOYSA-N 0.000 description 2
- RIWRBSMFKVOJMN-UHFFFAOYSA-N 2-methyl-1-phenylpropan-2-ol Chemical compound CC(C)(O)CC1=CC=CC=C1 RIWRBSMFKVOJMN-UHFFFAOYSA-N 0.000 description 2
- BDCFWIDZNLCTMF-UHFFFAOYSA-N 2-phenylpropan-2-ol Chemical compound CC(C)(O)C1=CC=CC=C1 BDCFWIDZNLCTMF-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- NUYKNLHRSQRUFY-UHFFFAOYSA-N N-[4-[2-(4-methylcyclohexyl)propan-2-yloxy]phenyl]-3-phenylprop-2-enamide Chemical compound C(C=CC1=CC=CC=C1)(=O)NC1=CC=C(C=C1)OC(C1CCC(CC1)C)(C)C NUYKNLHRSQRUFY-UHFFFAOYSA-N 0.000 description 2
- KDQZJDZJPLZMIZ-UHFFFAOYSA-N N-[4-[2-(4-methylcyclohexyl)propan-2-yloxy]phenyl]decanamide Chemical compound C1(CCC(CC1)C(C)(C)OC1=CC=C(NC(CCCCCCCCC)=O)C=C1)C KDQZJDZJPLZMIZ-UHFFFAOYSA-N 0.000 description 2
- WXBWGYYMKYXORR-UHFFFAOYSA-N N-methyl-4-[2-(4-methylcyclohexyl)propan-2-yloxy]aniline Chemical compound C1(CCC(CC1)C(C)(C)OC1=CC=C(NC)C=C1)C WXBWGYYMKYXORR-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- MIBQYWIOHFTKHD-UHFFFAOYSA-N adamantane-1-carbonyl chloride Chemical compound C1C(C2)CC3CC2CC1(C(=O)Cl)C3 MIBQYWIOHFTKHD-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003524 antilipemic agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000010531 catalytic reduction reaction Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 2
- 229960001214 clofibrate Drugs 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- RVOJTCZRIKWHDX-UHFFFAOYSA-N cyclohexanecarbonyl chloride Chemical compound ClC(=O)C1CCCCC1 RVOJTCZRIKWHDX-UHFFFAOYSA-N 0.000 description 2
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- DEFUSPNGFCCTEU-UHFFFAOYSA-N dicyclohexylmethanol Chemical compound C1CCCCC1C(O)C1CCCCC1 DEFUSPNGFCCTEU-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- KBNLYNNKZZJEGQ-UHFFFAOYSA-N ethyl N-[4-[2-(4-methylcyclohexyl)propan-2-yloxy]phenyl]carbamate Chemical compound C(C)OC(=O)NC1=CC=C(C=C1)OC(C1CCC(CC1)C)(C)C KBNLYNNKZZJEGQ-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- XFJAMQQAAMJFGB-ZQGJOIPISA-N (2s,3r,4r,5s,6r)-2-[3-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-4-ethylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound C1=C(CC=2C=C3OCCOC3=CC=2)C(CC)=CC=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XFJAMQQAAMJFGB-ZQGJOIPISA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- WOGITNXCNOTRLK-VOTSOKGWSA-N (e)-3-phenylprop-2-enoyl chloride Chemical compound ClC(=O)\C=C\C1=CC=CC=C1 WOGITNXCNOTRLK-VOTSOKGWSA-N 0.000 description 1
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 description 1
- MRWKKIPCEJZHIR-UHFFFAOYSA-N 1-(4-cyclohexyloxyphenyl)piperidine Chemical compound C1(CCCCC1)OC1=CC=C(C=C1)N1CCCCC1 MRWKKIPCEJZHIR-UHFFFAOYSA-N 0.000 description 1
- WDSDXRGLWTZFOU-UHFFFAOYSA-N 1-(4-octadecoxyphenyl)piperidine Chemical compound C(CCCCCCCCCCCCCCCCC)OC1=CC=C(C=C1)N1CCCCC1 WDSDXRGLWTZFOU-UHFFFAOYSA-N 0.000 description 1
- VTBOTOBFGSVRMA-UHFFFAOYSA-N 1-Methylcyclohexanol Chemical compound CC1(O)CCCCC1 VTBOTOBFGSVRMA-UHFFFAOYSA-N 0.000 description 1
- VMYIBQARIHBELG-UHFFFAOYSA-N 1-[4-(1,5-dimethyl-2-propan-2-ylcyclohexyl)oxyphenyl]piperidine Chemical compound CC1(CC(CCC1C(C)C)C)OC1=CC=C(C=C1)N1CCCCC1 VMYIBQARIHBELG-UHFFFAOYSA-N 0.000 description 1
- NMFLMLJPBJHWSE-UHFFFAOYSA-N 1-[4-(1-adamantyloxy)phenyl]piperidine Chemical compound C1CCCCN1C(C=C1)=CC=C1OC1(C2)CC(C3)CC2CC3C1 NMFLMLJPBJHWSE-UHFFFAOYSA-N 0.000 description 1
- TVGJIDDGGDRFML-UHFFFAOYSA-N 1-[4-(1-cyclohexylethoxy)phenyl]piperidine Chemical compound C1(CCCCC1)C(C)OC1=CC=C(C=C1)N1CCCCC1 TVGJIDDGGDRFML-UHFFFAOYSA-N 0.000 description 1
- WSUSYAFYTVEBKA-UHFFFAOYSA-N 1-[4-(1-methylcyclohexyl)oxyphenyl]piperidine hydrochloride Chemical compound Cl.CC1(CCCCC1)OC1=CC=C(C=C1)N1CCCCC1 WSUSYAFYTVEBKA-UHFFFAOYSA-N 0.000 description 1
- IXWQYJSIWKJUTR-UHFFFAOYSA-N 1-[4-(2-cyclohexylpropan-2-yloxy)phenyl]piperidine Chemical compound C1(CCCCC1)C(C)(OC1=CC=C(C=C1)N1CCCCC1)C IXWQYJSIWKJUTR-UHFFFAOYSA-N 0.000 description 1
- SIPMQGGJMMIZBA-UHFFFAOYSA-N 1-[4-(2-methylbutan-2-yloxy)phenyl]piperidine Chemical compound CC(CC)(OC1=CC=C(C=C1)N1CCCCC1)C SIPMQGGJMMIZBA-UHFFFAOYSA-N 0.000 description 1
- VVJTZCPDLMNFKB-UHFFFAOYSA-N 1-[4-(3,7-dimethyloctan-3-yloxy)phenyl]piperidine Chemical compound CC(CC)(CCCC(C)C)OC1=CC=C(C=C1)N1CCCCC1 VVJTZCPDLMNFKB-UHFFFAOYSA-N 0.000 description 1
- DNGUOPAGWXDWKJ-UHFFFAOYSA-N 1-[4-(3,7-dimethyloctoxy)phenyl]piperidine Chemical compound CC(CCOC1=CC=C(C=C1)N1CCCCC1)CCCC(C)C DNGUOPAGWXDWKJ-UHFFFAOYSA-N 0.000 description 1
- FQICZSRLFXBXGQ-UHFFFAOYSA-N 1-[4-(cyclohexylmethoxy)phenyl]piperidine Chemical compound C(OC1=CC=C(C=C1)N1CCCCC1)C1CCCCC1 FQICZSRLFXBXGQ-UHFFFAOYSA-N 0.000 description 1
- OGJIEWWSETTXAS-UHFFFAOYSA-N 1-[4-(dicyclohexylmethoxy)phenyl]piperidine Chemical compound C1(CCCCC1)C(OC1=CC=C(C=C1)N1CCCCC1)C1CCCCC1 OGJIEWWSETTXAS-UHFFFAOYSA-N 0.000 description 1
- YVKVXIBHSWQWDP-UHFFFAOYSA-N 1-[4-[2-(4-methylcyclohexyl)propan-2-yloxy]phenyl]pyrrolidine Chemical compound C1(CCC(CC1)C(C)(C)OC1=CC=C(C=C1)N1CCCC1)C YVKVXIBHSWQWDP-UHFFFAOYSA-N 0.000 description 1
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- FQKKVDFWNGLPOO-UHFFFAOYSA-N 1-cyclohexyl-1-phenylethanol Chemical compound C=1C=CC=CC=1C(O)(C)C1CCCCC1 FQKKVDFWNGLPOO-UHFFFAOYSA-N 0.000 description 1
- LLSKXGRDUPMXLC-UHFFFAOYSA-N 1-phenylpiperidine Chemical compound C1CCCCN1C1=CC=CC=C1 LLSKXGRDUPMXLC-UHFFFAOYSA-N 0.000 description 1
- NOGFHTGYPKWWRX-UHFFFAOYSA-N 2,2,6,6-tetramethyloxan-4-one Chemical compound CC1(C)CC(=O)CC(C)(C)O1 NOGFHTGYPKWWRX-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- FOYWCEUVVIHJKD-UHFFFAOYSA-N 2-methyl-5-(1h-pyrazol-5-yl)pyridine Chemical compound C1=NC(C)=CC=C1C1=CC=NN1 FOYWCEUVVIHJKD-UHFFFAOYSA-N 0.000 description 1
- GKWADRYHQORALS-UHFFFAOYSA-N 2-methyl-N-[4-[2-(4-methylcyclohexyl)propan-2-yloxy]phenyl]propanamide Chemical compound C(C(C)C)(=O)NC1=CC=C(C=C1)OC(C1CCC(CC1)C)(C)C GKWADRYHQORALS-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- UNSAJINGUOTTRA-UHFFFAOYSA-N 3-(3-bromophenyl)prop-2-yn-1-ol Chemical compound OCC#CC1=CC=CC(Br)=C1 UNSAJINGUOTTRA-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- WEDREPUFRGOQNK-UHFFFAOYSA-N 4-(1-cyclohexylethoxy)-N-hexadecylaniline Chemical compound C1(CCCCC1)C(C)OC1=CC=C(NCCCCCCCCCCCCCCCC)C=C1 WEDREPUFRGOQNK-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- XIJVKSMYKOQALT-UHFFFAOYSA-N 4-[2-(4-methylcyclohexyl)propan-2-yloxy]-N-tetradecylaniline Chemical compound C1(CCC(CC1)C(C)(C)OC1=CC=C(NCCCCCCCCCCCCCC)C=C1)C XIJVKSMYKOQALT-UHFFFAOYSA-N 0.000 description 1
- VPALDCKVTBGWAJ-UHFFFAOYSA-N 4-[2-(4-methylcyclohexyl)propan-2-yloxy]-n-phenylbenzamide Chemical compound C1CC(C)CCC1C(C)(C)OC1=CC=C(C(=O)NC=2C=CC=CC=2)C=C1 VPALDCKVTBGWAJ-UHFFFAOYSA-N 0.000 description 1
- VNTCGXMLDSKOKN-OAHLLOKOSA-N 4-[4-[[(3r)-3-methyl-4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]methyl]-1h-pyrazol-5-yl]benzonitrile Chemical compound C([C@H](N(CC1)C=2N=CC(=CC=2)C(F)(F)F)C)N1CC=1C=NNC=1C1=CC=C(C#N)C=C1 VNTCGXMLDSKOKN-OAHLLOKOSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- DTAZVWMFJGFKOZ-UHFFFAOYSA-N N,N-dimethyl-4-[2-(4-methylcyclohexyl)propan-2-yloxy]aniline Chemical compound C1(CCC(CC1)C(C)(C)OC1=CC=C(N(C)C)C=C1)C DTAZVWMFJGFKOZ-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- LKADJVXMSKUJOB-UHFFFAOYSA-N N-[4-(5-methyl-2-propan-2-ylcyclohexyl)oxyphenyl]adamantane-1-carboxamide Chemical compound C12(CC3CC(CC(C1)C3)C2)C(=O)NC2=CC=C(C=C2)OC2CC(CCC2C(C)C)C LKADJVXMSKUJOB-UHFFFAOYSA-N 0.000 description 1
- UPICDRCDUQREDN-UHFFFAOYSA-N N-ethyl-4-[2-(4-methylcyclohexyl)propan-2-yloxy]aniline Chemical compound C(C)NC1=CC=C(C=C1)OC(C1CCC(CC1)C)(C)C UPICDRCDUQREDN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- HVXJILXIZHJUAE-IYARVYRRSA-N [C@H]1(CC[C@H](CC1)C(C)(C)OC1=CC=C(C=C1)N1CCCCC1)C Chemical compound [C@H]1(CC[C@H](CC1)C(C)(C)OC1=CC=C(C=C1)N1CCCCC1)C HVXJILXIZHJUAE-IYARVYRRSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000005910 alkyl carbonate group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- YTFJQDNGSQJFNA-UHFFFAOYSA-L benzyl phosphate Chemical compound [O-]P([O-])(=O)OCC1=CC=CC=C1 YTFJQDNGSQJFNA-UHFFFAOYSA-L 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 125000005883 dithianyl group Chemical group 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- ARBOVOVUTSQWSS-UHFFFAOYSA-N hexadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCC(Cl)=O ARBOVOVUTSQWSS-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- LSACYLWPPQLVSM-UHFFFAOYSA-N isobutyric acid anhydride Chemical compound CC(C)C(=O)OC(=O)C(C)C LSACYLWPPQLVSM-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- GUOONOJYWQOJJP-DCMFLLSESA-N n-[(2s,3r)-3-hydroxy-1-phenyl-4-[[3-(trifluoromethoxy)phenyl]methylamino]butan-2-yl]-3-[methyl(methylsulfonyl)amino]-5-[(2r)-2-(4-methyl-1,3-thiazol-2-yl)pyrrolidine-1-carbonyl]benzamide Chemical compound C1([C@H]2CCCN2C(=O)C=2C=C(C=C(C=2)N(C)S(C)(=O)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)[C@H](O)CNCC=2C=C(OC(F)(F)F)C=CC=2)=NC(C)=CS1 GUOONOJYWQOJJP-DCMFLLSESA-N 0.000 description 1
- LIIWIMDSZVNYHY-UHFFFAOYSA-N n-hydroxy-2-[(1-phenylcyclopropyl)amino]pyrimidine-5-carboxamide Chemical compound N1=CC(C(=O)NO)=CN=C1NC1(C=2C=CC=CC=2)CC1 LIIWIMDSZVNYHY-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229930004008 p-menthane Natural products 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- CFJYNSNXFXLKNS-UHFFFAOYSA-N trans-p-menthane Natural products CC(C)C1CCC(C)CC1 CFJYNSNXFXLKNS-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N α-citronellol Chemical compound OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Foreliggende oppfinnelse angår en fremgangsmåte ved fremstilling av nye aminofenyletherforbindelser og farmakologisk akseptable salter, derav av formel I • The present invention relates to a process for the production of new aminophenyl ether compounds and pharmacologically acceptable salts, thereof of formula I •
hvori R-^ betegner hydrogenatom eller en lavere alkylgruppe, R 2 betegner en cyclohexylgruppe som kan være substituert med lavere alkylgrupper, en alkylgruppe inneholdende fra 1 til 20 carbonatomer, en fenylgruppe eller en benzylgruppe; R 3 betegner hydrogen-, atom, en lavere alkylgruppe eller en cyclohexylgruppe som kan være substituert med en lavere alkylgruppe, R^betegner hydrogenatom, en lavere alkylgruppe eller en lavere alkoxycarbonylgruppe, og R^betegner hydrogenatom, en arylgruppe eller gruppen vist ved -COR^ eller -CI-^Rg hvor Rg betegner hydrogenatom, en aminogruppe, en alkylgruppe inneholdende fra 1 til 19 carbonatomer, cyclohexylgruppe, en arylgruppe, en aralkylgruppe, en aralkenylgruppe, en aminogruppe substituert med lavere alkylgrupper, en hetérocyclisk gruppe som kan være substituert med lavere alkylgruppe, eller en brodannet hydrocarbongruppe, hvilke R2 og R3imidlertid sammen med det tilstøtende carbonatom kan danne en cyclohexanring som kan være substituert med lavere alkylgrupper og hvilke R^ og R^sammen med det tilstøtende nitrogenatom kan danne en pyrrolidin-ring eller en piperidinring-. Når i aminofenyletherforbindelsene vist ved formel I, gruppen vist ved wherein R-^ denotes a hydrogen atom or a lower alkyl group, R 2 denotes a cyclohexyl group which may be substituted with lower alkyl groups, an alkyl group containing from 1 to 20 carbon atoms, a phenyl group or a benzyl group; R 3 denotes a hydrogen atom, a lower alkyl group or a cyclohexyl group which may be substituted with a lower alkyl group, R^ denotes a hydrogen atom, a lower alkyl group or a lower alkoxycarbonyl group, and R^ denotes a hydrogen atom, an aryl group or the group shown by -COR ^ or -CI-^Rg where Rg denotes a hydrogen atom, an amino group, an alkyl group containing from 1 to 19 carbon atoms, cyclohexyl group, an aryl group, an aralkyl group, an aralkenyl group, an amino group substituted with lower alkyl groups, a heterocyclic group which may be substituted with lower alkyl group, or a bridged hydrocarbon group, which R2 and R3 can, however, together with the adjacent carbon atom form a cyclohexane ring which can be substituted with lower alkyl groups and which R^ and R^ together with the adjacent nitrogen atom can form a pyrrolidine ring or a piperidine ring- . When in the aminophenyl ether compounds shown by formula I, the group shown at
har en di-substituert cyclohexanring, has a di-substituted cyclohexane ring,
foreligger det cis- og. trans-stereoisomerer av disse, og forbindelsene ifølge oppfinnelsen innbefatter disse stereoisomere. there are cis- and. trans stereoisomers thereof, and the compounds according to the invention include these stereoisomers.
Angivelsen "lavere alkylgrupper" som anvendes i denne beskrivelse innbefatter rettkjedede eller forgrenede alkylgrupper inneholdende fra 1 til 6 carbonatomer slik som methylgruppe, ethylgruppe, isopropylgruppe, biitylgruppe, isopentylgruppe, hexylgruppe etc. Som "arylgruppe" kan.nevnes fenylgruppe, nafthylgruppe etc, som "aralkylgruppe" kan f.eks. nevnes benzylgruppe, fenethylgruppe, fenylpropylgruppe etc, som "lavere alkox.ycarbonylgruppe " kan nevnes methoxycarbonylgruppe, ethoxy-carbonylgruppe, butoxycarbonylgruppe etc, og som "aaralkenyl-gruppe" kan nevnes styrylgruppe, ciannmylgruppe etc, og som "heterocyklisk gruppe" kan névnes pyrrolylgruppe, furylgruppe, thienylgruppe, oxazolynylgruppe, pyridylgruppe, thiazolylgruppe, thiadiazolylgruppe, dithianylgruppe, pyrimidinylgruppe, pipera-dinylgruppe, morfolingruppe etc. Som "brodannet hydrocarbongruppe" kan f.eks. nevnes bicyclonohanylgruppe, bicyclodecanyl-gruppe, adamantyTgruppe, pinanylgruppe, bornylgruppe. The term "lower alkyl groups" used in this description includes straight-chain or branched alkyl groups containing from 1 to 6 carbon atoms such as methyl group, ethyl group, isopropyl group, biethyl group, isopentyl group, hexyl group, etc. As "aryl group" can be mentioned phenyl group, naphthyl group, etc., such as " aralkyl group" can e.g. mention is made of benzyl group, phenethyl group, phenylpropyl group etc, as "lower alkoxycarbonyl group" can be mentioned methoxycarbonyl group, ethoxy-carbonyl group, butoxycarbonyl group etc, and as "araalkenyl group" can be mentioned styryl group, cyanmyl group etc, and as "heterocyclic group" can be mentioned pyrrolyl group, furyl group, thienyl group, oxazolynyl group, pyridyl group, thiazolyl group, thiadiazolyl group, dithianyl group, pyrimidinyl group, piperadinyl group, morpholine group, etc. As "bridged hydrocarbon group" can e.g. bicyclonohanyl group, bicyclodecanyl group, adamantyl group, pinanyl group, bornyl group are mentioned.
Som farmakolotisk akseptable salter av forbindelsene av formel I kan nevnes salter med en uorganisk syre slik som saltsyre, hydrobromsyre, fosforsyré etc, salter med organisk syre slik som maursyre, eddiksyre, melkesyre, oxalsyre, ravsyre, fumarsyre, benzoesyre, benzensulfonsyre, etc og også kvartære ammoniumsalter erholdt ved omsetning med et alkylhalogenid slik som methyljodid etc. As pharmacologically acceptable salts of the compounds of formula I, mention may be made of salts with an inorganic acid such as hydrochloric acid, hydrobromic acid, phosphoric acid, etc., salts with an organic acid such as formic acid, acetic acid, lactic acid, oxalic acid, succinic acid, fumaric acid, benzoic acid, benzenesulfonic acid, etc. and also quaternary ammonium salts obtained by reaction with an alkyl halide such as methyl iodide etc.
Forbindelsene av formel I har hypolipermisk aktivitet og også særlig god cholesterol og triglycerid-reduserende aktivitet og er effektive for profylaktisk og medisinsk behandling av arteriosclerosis slik som hjertecoronarsykdom. The compounds of formula I have hypoliperemic activity and also particularly good cholesterol- and triglyceride-reducing activity and are effective for prophylactic and medical treatment of arteriosclerosis such as coronary heart disease.
Det er angitt at arteriosclerosis bevirkes delvis.av uvanligøkende mengde av lipider slik som cholesterol, triglycerid' etc, i blodet. Et hypolipemisk middel, p-klo.rf enoxy-iso-smørsyreethylester . (Clofibrat) har hittil hyppig blitt anvendt men det foreligger et behov for å utvikle medikamenter med mer effektiv hypolipemisk aktivitet og mindre sideeffekt. It has been stated that arteriosclerosis is partly caused by an abnormally increasing amount of lipids such as cholesterol, triglycerides, etc., in the blood. A hypolipemic agent, p-chloro.rf enoxy-iso-butyric acid ethyl ester. (Clofibrate) has so far been frequently used, but there is a need to develop drugs with more effective hypolipemic activity and fewer side effects.
Det er nå funnet at forbindelsene av formel I har en cholesterol og triglyceridreduserende aktivitet og en aktivitet når det gjelder å øke høy tetthet lipoprotein (HDL) cholesterol selektivt. It has now been found that the compounds of formula I have a cholesterol and triglyceride reducing activity and an activity in selectively increasing high density lipoprotein (HDL) cholesterol.
Det er kjent at mengden av HDL i blod er lavere i arteriosclerosis enn i menneskets normaltilstand og at også HDL forhindrer den økende akkumulering av cholesterol på arter-ieveg-gen og aktiverer fjerning av cholesterol fra arterieveggen i for-søksdyr. Derfor kan en økning av HDL cholesterol være effektiv når det gjelder profylaktisk og medisinsk behandling av arteriosclerosis. Imidlertid utviser det konvensjonelle hypolipemiske middel som som Clofibrate, ikke noen aktivitet når det gjelder økning av HDL cholesterol selektivt. Som en forbindelse som utviser en aktivitet når det gjelder å øke HDL cholesterol, er en N-[p-(1-adamantyloxy)fenyl]piperidin (U-41.792) beskrevet i US patentskrift 4 036 977, men aktiviteten av forbindelsene fremstilt ifølge foreliggende oppfinnelse er klart bedre enn denne kjente forbindelse som vil bli vist i det etterfølgende. It is known that the amount of HDL in blood is lower in arteriosclerosis than in the normal human condition and that HDL also prevents the increasing accumulation of cholesterol on arterial walls and activates the removal of cholesterol from the arterial wall in experimental animals. Therefore, an increase in HDL cholesterol can be effective in the prophylactic and medical treatment of arteriosclerosis. However, the conventional hypolipemic agent such as Clofibrate does not show any activity in raising HDL cholesterol selectively. As a compound exhibiting an activity in raising HDL cholesterol, an N-[p-(1-adamantyloxy)phenyl]piperidine (U-41,792) is disclosed in US Patent 4,036,977, but the activity of the compounds prepared according to the present invention is clearly better than this known compound which will be shown in the following.
Forsøk 1Attempt 1
3. uker gamle Sprague-Dawley-hanrotter ble podet i 7 dager med halvrenset diet inneholdende 1,5 % cholesterol og 0,5 3-week-old male Sprague-Dawley rats were inoculated for 7 days with semipurified diet containing 1.5% cholesterol and 0.5
% gallesyre for å fremkalle hypercholesterolemia. % bile acid to induce hypercholesterolemia.
En forbindelse fremstilt ifølge oppfinnelsen suspendert i en vandig løsning inneholdende 0,25 % methylcellulose ble.admi-nistrert til disse én gang pr. dag ved oral administrering i .4 A compound prepared according to the invention suspended in an aqueous solution containing 0.25% methylcellulose was administered to these once per day by oral administration in .4
dager. Etter fasting over natten ble dyrene pedøvet med ether og blodet ble erholdt fra de perifere kar, og HDL-bundet. cholesterol days. After fasting overnight, the animals were anesthetized with ether and the blood was obtained from the peripheral vessels, and HDL bound. cholesterol
(cholesterol av .HDL) i serum ble bestemt. Resultatene er vist i den etterfølgende tabell. I tillegg ble bestemmelse av total cholesterol foretatt etter den metode som er beskrevet i Schettler G&Nussel; "Arbeitsmed. Sozialmed. Praventivmed.", (cholesterol of .HDL) in serum was determined. The results are shown in the following table. In addition, total cholesterol was determined according to the method described in Schettler G&Nussel; "Occupational medicine. Sozialmed. Praventivmed.",
10, 25 (1975) og bestemmelsen av HDL-bundet cholesterol ble utført etter den bmetode som er beskrevet i T.T. Ishikawa et al.,. "Lipids", 11, 628 (1976).. 10, 25 (1975) and the determination of HDL-bound cholesterol was carried out according to the method described in T.T. Ishikawa et al.,. "Lipids", 11, 628 (1976)..
xl: N-p-(1-adamantyloxy)fenyl-piperidin (US patent 4 036 977) xl: N-p-(1-adamantyloxy)phenyl-piperidine (US Patent 4,036,977)
-2: VLDL: lipoprotein med meget lav densitet -2: VLDL: lipoprotein with very low density
LDL : lipoprotein med lav densitetLDL: low-density lipoprotein
Forsøk 2Attempt 2
Ved å følge samme prosedyre som i forsøk \ 1 under anvendelse av 4 uker gamle Sprague-Dawlay hanrotter ble total kolesterol i serum og HDL-bundet kolesterol bestemt på samme måte som beskrevet i forsøk 1. Resultatene er vist i de etter-følgende tabeller. By following the same procedure as in experiment 1 using 4-week-old male Sprague-Dawlay rats, total serum cholesterol and HDL-bound cholesterol were determined in the same way as described in experiment 1. The results are shown in the following tables.
Som det klart fremgår fra de ovenfor angitte forsøks-resultater har forbindelsene av formel I ikke bare en glimrende kolesterol-reduserende aktivitet men øker også mengden av HDL sterkt hvilket som kjent aktiverer fjerning av kolesterol fra arterieveggen. Derfor er. forbindelsene fremstilt ifølge oppfinnelsen meget effektive for profylaksisk og medisinsk behandling av arteriosclerosis. As is clear from the test results stated above, the compounds of formula I not only have an excellent cholesterol-reducing activity but also greatly increase the amount of HDL, which, as is known, activates the removal of cholesterol from the arterial wall. Therefore is. the compounds produced according to the invention are very effective for the prophylactic and medical treatment of arteriosclerosis.
Forbindelsene av formel I kan formes i forskjellige formuleringer slik som pulvere, granuler, tabletter, kapsler, injeksjonløsninger etc. under anvendelse av de additiver som vanligvis anvendes for slike formuleringer. Det foretrekkes at. forbindelsene administreres oralt. Dosene av forbindelsene avhenger av tilstanden, alder etc. av pasienten, men når det gjelder oral administrering vil dosen vanligvis være 1 - 100 mg/kg, fortrinnsvis 5 - 25 g/kg pr. dag for én voksen pasient. The compounds of formula I can be formed in various formulations such as powders, granules, tablets, capsules, injection solutions etc. using the additives which are usually used for such formulations. It is preferred that. the compounds are administered orally. The doses of the compounds depend on the condition, age etc. of the patient, but in the case of oral administration the dose will usually be 1 - 100 mg/kg, preferably 5 - 25 g/kg per day for one adult patient.
Forbindelsene av formel I kan fremstilles etter forskjellige fremgangsmåter og kan for eksempel fremstilles ved fremgangsmåte 1-5 vist i det etterfølgende reaksjonssk jerna: .- a The compounds of formula I can be prepared by different methods and can, for example, be prepared by methods 1-5 shown in the following reaction scheme: .- a
Forbindelsene av formel I innbefatter således forbin-deisene av formel II, V, VII, VIII, X og XII. The compounds of formula I thus include the compounds of formula II, V, VII, VIII, X and XII.
De ovenfor beskrevne fem fremgangsmåter beskrives i detalj i det etterfølgende. The five methods described above are described in detail in what follows.
Fremgang små t,e_l£Progress small t,e_l£
Ved denne fremgangsmåte kan forbindelsene vist ved By this method, the compounds shown by
formel IIformula II
hvori RlfR2og R3 har de tidligere angitte betydninger, erholdes ved omsetning av alkoholforbindelsen vist ved formel III hvori R-j^, R2 og R3har de ovenfor angitte betydninger, og p-halogennitrobenzen vist ved formel IV: in which R 1 R 2 and R 3 have the previously indicated meanings, is obtained by reacting the alcohol compound shown by formula III in which R-j^, R 2 and R 3 have the meanings indicated above, and p-halogenitrobenzene shown by formula IV:
hvori X betegner et halogenatom, i nærvær av en sterk base, wherein X denotes a halogen atom, in the presence of a strong base,
hvoretter produktet reduseres.after which the product is reduced.
Det foretrekkes at reaksjonen utføres under oppvarming i et organisk løsningsmiddel slik som benzen, toluen, xylen, dimethylfomramid, dimethylsulfoxyd, tetrahydrofuran, dioxan, eller et blandet løsningsmiddel derav. Foretrukne eksempler på. den sterke base som anvendes ved denne fremgangsmåte er natrium, kalium, lithium, natriumhydrid, kaliumhydrid, lithiumhydrid etc. I dette tilfelle foretrekkes det at alkoholforbindelsen av formel III omsettes med den sterke base på forhånd og at produktet der- . etter omsettes med p-halogennitrobenzenet av formel IV. It is preferred that the reaction is carried out under heating in an organic solvent such as benzene, toluene, xylene, dimethylformamide, dimethylsulfoxide, tetrahydrofuran, dioxane, or a mixed solvent thereof. Preferred examples of. the strong base used in this method is sodium, potassium, lithium, sodium hydride, potassium hydride, lithium hydride etc. In this case it is preferred that the alcohol compound of formula III is reacted with the strong base beforehand and that the product there-. after reacting with the p-halogenitrobenzene of formula IV.
Reduksjonen kan utføres på kjent måte, for eksempel ved katalytisk reduksjon i hydrogenatmosfære under anvendelse av en The reduction can be carried out in a known manner, for example by catalytic reduction in a hydrogen atmosphere using a
katalysator slik som Raney-nikkelkatalysator, platina, palladium, eller ved reduksjon under sure betingelser under anvendelse av et catalyst such as Raney nickel catalyst, platinum, palladium, or by reduction under acidic conditions using a
metall slik som jern, zink, tinn etc. Den katalytiske reduksjon kan ikke bare bevirke reduksjon av nitrogruppen men også hydro- metal such as iron, zinc, tin etc. The catalytic reduction can not only cause reduction of the nitro group but also hydro-
genering av dobbeltbindingen som foreligger i gruppen generation of the double bond present in the group
Fr emgangsmåte 2; Method 2;
Ved denne fremgangsmåte kan forbindelsen vist ved formel V: By this method, the compound shown by formula V:
hvori R^, R2, R^ og R^ har de ovenfor angitte betydninger, erholdes ved.omsetning av forbindelsen vist ved formel II i fremgangsmåte 1: '.• og en carboxylsyre vist ved formel VI: in which R^, R2, R^ and R^ have the meanings given above, is obtained by reacting the compound shown by formula II in method 1: '.• and a carboxylic acid shown by formula VI:
hvori Rg har den ovenfor angitte betydning, eller dets reaktive derivat. wherein Rg has the above meaning, or its reactive derivative.
Det foretrekkes å utføre reaksjonen under avkjøling eller ved romtemperatur i et organisk løsningsmiddel slik som benzen, toluen, xyle.n, dimethylf ormamid, dimethylsulf oxyd, tetrahydrofuran, pyridin, dioxan etc, eller et blandet løsningsmiddel av disse. Ved anvendelse av carboxylsyren av formel VI ved denne reaksjon er det bedre å utføre reaksjonen i nærvær av et konden-seringsmiddel slik som dicyclohexylcarbodiimid. Som de réaktive derivater av carboxylsyren av formel VI kan nevnes syrehalogeni-der slik som syreklorid, syrebromid etc, blandede syreanhydrider slik som benzylf osf at, alkylcarbonat, pivalinsyre etc, aktive estere slik som p-nitrofenylester, thiofenylester etc. og syre-anhydr ider. It is preferred to carry out the reaction under cooling or at room temperature in an organic solvent such as benzene, toluene, xylene, dimethylformamide, dimethylsulfoxide, tetrahydrofuran, pyridine, dioxane, etc., or a mixed solvent of these. When using the carboxylic acid of formula VI in this reaction, it is better to carry out the reaction in the presence of a condensing agent such as dicyclohexylcarbodiimide. As the reactive derivatives of the carboxylic acid of formula VI, acid halides such as acid chloride, acid bromide etc., mixed acid anhydrides such as benzyl phosphate, alkyl carbonate, pivalic acid etc., active esters such as p-nitrophenyl ester, thiophenyl ester etc. and acid anhydrides can be mentioned .
Ved denne fremgangsmåte kan forbindelsene vist ved formel VII: By this method, the compounds shown by formula VII can:
eller formel VIII hvori betegner en alkylgruppe inneholdende fra 1 til 20 carbonatomer, en arylgruppe, en aralkylgruppe eller en lavere alkoxycarbonylgruppe, R^<1>betegner en lavere alkylgruppe, og R-^, og R^har de ovenfor angitte betydninger, erholdes ved omsetning av forbindelsene vist ved formel II i fremgangsmåte I: og forbindelsen vist ved formel IX or formula VIII in which denotes an alkyl group containing from 1 to 20 carbon atoms, an aryl group, an aralkyl group or a lower alkoxycarbonyl group, R^<1> denotes a lower alkyl group, and R-^, and R^ have the meanings given above, obtained by reaction of the compounds shown by formula II in process I: and the compound shown by formula IX
hvori R^ og X har de ovenfor angitte betydninger. in which R^ and X have the meanings given above.
Foretrukne eksempler på halogenatornet er bromatom og jodatom. Det foretrekkes å utføre reaksjonen ved romtemperatur eller under oppvarming i et organisk løsningsmiddel slik som benzen, toluen, xylen, dimethylformamid,. dimethylsulfoxyd, dioxan, tetrahydrof uran, pyr idin, methanol, ethanol etc, eller et blandet løsningsmiddel av disse, i nærvær av et basisk middel slik som natriumcarbonat, kaliumcarbonat .etc. Preferred examples of the halogen atom are bromine and iodine. It is preferred to carry out the reaction at room temperature or under heating in an organic solvent such as benzene, toluene, xylene, dimethylformamide. dimethyl sulfoxide, dioxane, tetrahydrofuran, pyridine, methanol, ethanol etc., or a mixed solvent of these, in the presence of a basic agent such as sodium carbonate, potassium carbonate .etc.
Ved denne fremgangsmåte kan forbindelsen vist ved formel X: By this method, the compound shown by formula X:
hvori Rg betegner -(CH,,)^- eller -(CI^)^- og R-^, R2 og R^ har de ovenfor angitte betydninger, erholdes ved omsetning av forbin- in which Rg denotes -(CH,,)^- or -(CI^)^- and R-^, R2 and R^ have the above-mentioned meanings, obtained by reacting compounds
deisen vist ved formel II i fremgangsmåte 1: og forbindelsen vist ved formel XI: the deisen shown by formula II in method 1: and the compound shown by formula XI:
hvori Rg og X har de. foran angitte betydninger, und<r>er samme reak-sjonsbetingelser som anvendes ved fremgangsmåte 3. in which Rg and X have de. meanings given above, and are the same reaction conditions as used in method 3.
Ved denne fremgangsmåte kan forbindelsen vist ved formel By this method, the compound can be shown by formula
XII:XII:
hvori R-^, R2, R-j og. R^ har de ovenfor angitte betydninger, erhol- . des ved reduksjon av forbindelsene vist ved formel V: wherein R-^, R2, R-j and. R^ has the meanings stated above, erhol- . des by reduction of the compounds shown by formula V:
under anvendelse av et reduksjonsmiddel slik som lithiumaluminiumhydrid, diboran etc., i et organisk løsningsmiddel slik som tetrahydrofuran, ether etc. under fortrinnsvis oppvarming. using a reducing agent such as lithium aluminum hydride, diborane etc., in an organic solvent such as tetrahydrofuran, ether etc. preferably under heating.
Ennvidere kan følgende reaksjoner utføres under anvendelse av de forbindelser som erholdes ved de ovenfor angitte fremgangsmåter. Furthermore, the following reactions can be carried out using the compounds obtained by the methods indicated above.
I de etterfølgende formler betegner AIn the following formulas, A denotes
hvor X har den ovenfor angitte betydning. where X has the meaning given above.
Hvis i de ovenfor angitte fremgangsmåter cis-forbindel- If in the above methods cis-compound-
sen av alkoholf orbindelsen av formel III anvendes, erholdes cis- <• isomeren av forbindelsen av formel I, og hvis transforbindelsen av alkoholforbindelsen av formel III anvendes, erholdes trans-isomeren av forbindelsen av.formel I. Hvis en blanding av cis-trans-isomeren av alkoholforbindelsen av formel III anvendes, erholdes en blanding av cis-trans-isomeren av forbindelsen av formel I og i dette tilfelle kan cis-forbindelsen eller transforbindelsen isoleres fra hverandre ved vanlig separåsjonsprose-dyre slik som fraksjonert krystallisasjon. If the alcohol compound of formula III is used, the cis isomer of the compound of formula I is obtained, and if the trans isomer of the alcohol compound of formula III is used, the trans isomer of the compound of formula I is obtained. If a mixture of cis-trans- isomer of the alcohol compound of formula III is used, a mixture of the cis-trans isomer of the compound of formula I is obtained and in this case the cis-compound or the trans-compound can be isolated from each other by ordinary separation procedures such as fractional crystallization.
De etterfølgende eksempler illustrerer oppfinnelsen. The following examples illustrate the invention.
Eksemp_el_lExample_el_l
I 120 ml av en blanding av dimethylformamid og benzen i et volumforhold på 1 : 2 ble oppløst 5,1 g p-menthen-8-ol og .etter tilsetning av 1,6 g natriumhydrid (50 % suspensjon i en mineralolje) ble blandingen kokt under tilbakeløpskjøling i 30 minutter. Etter avkjøling av reaksjonsblandingen ble 4,7 g p-fluornitrobenzen dråpevis tilsatt til blandingen og den resulte-rnde blanding ble kokt under tilbakeløpskjøling i 6 timer. Etter avkjøling av reaks jonsblandingen ble 200 ml benzen tilsatt', blandingen ble vasket med vann og deretter med en vandig hatriumklo-ridløsning. In 120 ml of a mixture of dimethylformamide and benzene in a volume ratio of 1:2, 5.1 g of p-menthen-8-ol were dissolved and, after the addition of 1.6 g of sodium hydride (50% suspension in a mineral oil), the mixture boiled under reflux for 30 minutes. After cooling the reaction mixture, 4.7 g of p-fluoronitrobenzene was added dropwise to the mixture and the resulting mixture was boiled under reflux for 6 hours. After cooling the reaction mixture, 200 ml of benzene were added, the mixture was washed with water and then with an aqueous sodium chloride solution.
Denzenlaget ble fraskilt og tørket over vannfritt natriumsulfat. Løsningsmidlet ble destillert fra under redusert trykk. Residuet ble anbragt på en silicagelkolonne og det ønskede produkt ble eluert under anvendelse av en ekvivalent blanding av benzen og hexan. Ved avdestillering av løsningsmidlet fra eluatet under redusert trykk ble det erholdt 7,2 g 4-(1-p-menthen-; 8-yloxy)hitrobenzen; En blanding av dette produkt og 0,7.g 10. %-ig palladiumcarbon i 100 ml ethylacetat ble ristet under hydrogen inntil den teoretiske mengde av hydrogen var absorbert.. Etter filtrering av palladiumcarbon, ble løsningsmidlet destillert fra , under redusert trykk og residuet ble destillert under redusert trykk under dannelse av 5,07 g 4-(p-menthen-8-yloxy)-anilin. The denzen layer was separated and dried over anhydrous sodium sulfate. The solvent was distilled from under reduced pressure. The residue was applied to a silica gel column and the desired product was eluted using an equivalent mixture of benzene and hexane. By distilling off the solvent from the eluate under reduced pressure, 7.2 g of 4-(1-p-menthen-; 8-yloxy)hydrobenzene were obtained; A mixture of this product and 0.7 g of 10% palladium carbon in 100 ml of ethyl acetate was shaken under hydrogen until the theoretical amount of hydrogen was absorbed. After filtering the palladium carbon, the solvent was distilled from , under reduced pressure and the residue was distilled under reduced pressure to give 5.07 g of 4-(p-menthen-8-yloxy)-aniline.
Kokepunkt: 14 6 - 148° C/0,3 mm Hg Elementæranalyse for C^gH^NO: Boiling point: 14 6 - 148° C/0.3 mm Hg Elemental analysis for C^gH^NO:
Beregnet: C m',' 68. %, H 10,19 N 5,66 %Calculated: C m',' 68. %, H 10.19 N 5.66 %
Funnet : C 77,73 %, H 10,20'%,.- N 5,64 % Found: C 77.73%, H 10.20%,.- N 5.64%
Eksemp_el_2Example_el_2
I 670 ml av en blanding av dimethylformamid og- benzen In 670 ml of a mixture of dimethylformamide and benzene
i et volumforhold på 1:2 ble oppløst 3.1,2 g cis-p-menthan-8-ol, og etter tilsetning av 8,0 g natriumhydrid (60 %-ig suspensjon i in a volume ratio of 1:2, 3.1.2 g of cis-p-menthan-8-ol were dissolved, and after the addition of 8.0 g of sodium hydride (60% suspension in
en mineralolje) ble blandingen kokt under tilbakeløpskjøling i 30 ' minutter. Etter avkjøling ble 28,2 g p-fluornitrobenzen dråpevis tilsatt til blandingen og den resulterende blanding ble ytterligere, kokt under tilbakeløpskjøling i 6 timer. Etter avkjøling ble 400 ml benzen tilsatt til blandingen og den resulterende blanding ble vasket med vann og en vandig natriumkloridløsning. Benzenlaget ble tørket over vannfritt natriumsulfat. Etter fra-destillering av løsningsmidlet under redusert trykk ble det dannede residuum anbragt på silicagelkolonne og det ønskede produkt ble eluert under anvendelse av en ekvivalent blanding av benzen og hexan hvoretter løsningsmidlet ble destillert'fra eluatet under, redusert trykk under dannelse av 49 g cis-4-(p-menthan-8-yloxy) ni trobenzen med et kokepunkt på 18.0 - 183° C/0,7 mm Hg. a mineral oil) the mixture was boiled under reflux for 30 minutes. After cooling, 28.2 g of p-fluoronitrobenzene was added dropwise to the mixture and the resulting mixture was further refluxed for 6 hours. After cooling, 400 ml of benzene was added to the mixture and the resulting mixture was washed with water and an aqueous sodium chloride solution. The benzene layer was dried over anhydrous sodium sulfate. After distilling off the solvent under reduced pressure, the residue formed was placed on a silica gel column and the desired product was eluted using an equivalent mixture of benzene and hexane after which the solvent was distilled from the eluate under reduced pressure to form 49 g of cis- 4-(p-menthan-8-yloxy) nitrobenzene with a boiling point of 18.0 - 183° C/0.7 mm Hg.
En blanding av 44 g av -produktet og 2 g 10 %-ig palladiumcarbon i 200 ml ethylacetat ble ristet under hydrogenatmosfære inntil en teoretisk mengde av hydrogen var. blitt absorbert. Etter filtrering av palladiumcarbon ble løsningsmidlet destillert fra under redusert trykk og residuet ble avdestillert under redusert, trykk under dannelse av 39,4 g cis-4-(p-menthan-8-yl-oxy)anilin. A mixture of 44 g of the product and 2 g of 10% palladium carbon in 200 ml of ethyl acetate was shaken under a hydrogen atmosphere until a theoretical amount of hydrogen was. been absorbed. After filtration of palladium carbon, the solvent was distilled off under reduced pressure and the residue was distilled off under reduced pressure to give 39.4 g of cis-4-(p-menthan-8-yl-oxy)aniline.
Kokepunkt: 152 - 154° C/l mm HgBoiling point: 152 - 154° C/l mm Hg
Elementæranalyse f or .C-^ 5H25NO: ■-• Elementary analysis for .C-^ 5H25NO: ■-•
Beregnet: C 77,68 %, H 10,19 %, N 5,66 %Calculated: C 77.68%, H 10.19%, N 5.66%
Funnet. : C 77,70 %, H 10,22. %, N 5,65 %<.>"<,>'<1>Found. : C 77.70%, H 10.22. %, N 5.65%<.>"<,>'<1>
Eksemgel_3 Eczema gel_3
Ved å følge den samme prosedyre som beskrevet i eksempel 2 under anvendelse av trans-p-menthan-8-ol i stedet for cis-p-menthan-8-ol, ble trans-4-(p-menthan-8-yloxy)nitrobenzen erholdt med et kokepunkt på 168 - 171°C/1 mm Hg, og ved behandling av produktet som beskrevet i eksempel 2, ble trans-4-(p-menthan-8-. yloxy)anilin erholdt. Following the same procedure as described in Example 2 using trans-p-menthan-8-ol instead of cis-p-menthan-8-ol, trans-4-(p-menthan-8-yloxy) nitrobenzene obtained with a boiling point of 168 - 171°C/1 mm Hg, and by treating the product as described in Example 2, trans-4-(p-menthan-8-.yloxy)aniline was obtained.
Kokepunkt: 141 - 143°C/0,6 mm Hg Elementæranalyse for C-j^H^NO: Beregnet: C 77,68 %, H 10,19 %, N 5,66 % Funnet : C 77,86%, H 10,31 %, N 5,64 % Boiling point: 141 - 143°C/0.6 mm Hg Elemental analysis for C-j^H^NO: Calculated: C 77.68%, H 10.19%, N 5.66% Found: C 77.86%, H 10 .31%, N 5.64%
Eksempe1_4Example 1_4
I 100 ml av en ekvivalent blanding av tetrahydrofuran og pyridin ble oppløst 10 g 4-(p-menthan-8-yloxy)anilin, og etter dråpevis tilsetning til løsningen av 8 ml eddiksyreanhydrid under isavkjøling ble blandingen omført over natten ved romtemperatur. Reaksjonsblandingen ble heldt over i 300 g is etterfulgt av omrø-ring i 2 timer hvoretter de utfelte krystaller ble oppsamlet ved filtrering, vasket med vann og omkrystallisert fra 50 ml ethanol under dannelse av 6,7 g hvitt, krystallinsk 4-(p-menthan-8-yloxy)-acetanilid. In 100 ml of an equivalent mixture of tetrahydrofuran and pyridine, 10 g of 4-(p-menthan-8-yloxy)aniline were dissolved, and after the dropwise addition of 8 ml of acetic anhydride to the solution under ice cooling, the mixture was stirred overnight at room temperature. The reaction mixture was poured into 300 g of ice followed by stirring for 2 hours, after which the precipitated crystals were collected by filtration, washed with water and recrystallized from 50 ml of ethanol to form 6.7 g of white, crystalline 4-(p-menthane) -8-yloxy)-acetanilide.
Smeltepunkt: .119 - 120° CMelting point: .119 - 120° C
Elementæranalyse for C^g^-^NO: Elemental analysis for C^g^-^NO:
Beregnet: C 74,70 %, H 9,40 %, N 4,84 %Calculated: C 74.70%, H 9.40%, N 4.84%
Funnet : C 74,61 %, H 9,65 %, N 4,73 % Found : C 74.61%, H 9.65%, N 4.73%
Ved å anvende lignende fremgangsmåte som beskrevet i eksempel 1 men å anvende andre alkoholforbindelser i stedet for p-menthen-8-ol i eksempel .1, ble andre anlinderivater erholdt og disse ble omsatt med eddiksyreanhydrid ved lignende fremgangsmåte som beskrevet i eksempel 4 under dannelse av forbindelsene angitt i eksempler 5 - 19. By using a similar method as described in example 1 but using other alcohol compounds instead of p-menthen-8-ol in example .1, other aniline derivatives were obtained and these were reacted with acetic anhydride by a similar method as described in example 4 forming of the compounds indicated in examples 5 - 19.
Eksemp_el_5Example_el_5
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
Ønsket forbindelse Desired connection
4-(p-menthan-3-yloxy)acetanilid 4-(p-menthan-3-yloxy)acetanilide
Smeltepunkt: 133 - 134° CMelting point: 133 - 134° C
Elementæranalyse for C^gH^NC^'-Elemental analysis for C^gH^NC^'-
Beregnet: C 74,70 %, W 9,40 %, N 4,84 % Calculated: C 74.70%, W 9.40%, N 4.84%
Funnet : C 74 , 45 %, H 9,64 %, N 4,56 % Found : C 74 , 45%, H 9.64%, N 4.56%
Eksemgel_6Eczema gel_6
Alkoholforbindelse anvendt som utgangsmateriale . 3., 7-dimethyl-3-oxy-l, 6-octadien. Alcohol compound used as starting material. 3.,7-dimethyl-3-oxy-1,6-octadiene.
Ønsket forbindelseDesired connection
4-(3,7-dimethyioct-3-yloxy)acetanilid Smeltepunkt: 50.- 51° C 4-(3,7-dimethyioct-3-yloxy)acetanilide Melting point: 50.- 51° C
Elementæranalyse for C^gH^NC^:Elemental analysis for C^gH^NC^:
Beregnet: C 74,18%, H 10,03 %, N 4,81 % Funnet : C 74,19%, H 9,89 %, N 4,54 % Calculated: C 74.18%, H 10.03%, N 4.81% Found: C 74.19%, H 9.89%, N 4.54%
Eksemgel_7Eczema gel_7
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
1,1-dimethylpropanol Ønsket forbindelse 1,1-dimethylpropanol Desired compound
4-(1,1-dimethylpropoxy)acetanilid Smeltepunkt: 116 - 117° C 4-(1,1-dimethylpropoxy)acetanilide Melting point: 116 - 117° C
Elementæranalyse for C13HigN02:Elemental analysis for C13HigN02:
Beregnet: C 70,56 H 8,65 %, N.6,33 % Funnet : C 70,54 %, H 8,80 %, N 6,33 %. Calculated: C 70.56 H 8.65%, N.6.33% Found: C 70.54%, H 8.80%, N 6.33%.
Eksemgel 8Example 8
Alkoholforbindelse anvendt som utgangsmateriale. Alcohol compound used as starting material.
Cyclohexylmethanol. Cyclohexylmethanol.
Ønsket forbindelse Desired connection
4-(cyclohexylmethoxy)acetanilid Smeltepunkt: 118 - 119° C Elementæranalyse for ci5H2iN02: 4-(cyclohexylmethoxy)acetanilide Melting point: 118 - 119° C Elemental analysis for ci5H2iN02:
Beregnet-: C.72,84 %, H 8,56 %, N 5,66 %Calculated-: C.72.84%, H 8.56%, N 5.66%
Funnet : C 72,66 %, H 8,57 N .5,82 % Found : C 72.66%, H 8.57 N .5.82%
Eksemp_el_9Example_el_9
Alkoholforbindelse som utgangsmaterialeAlcohol compound as starting material
- 1-cyclohexylethanol Ønsket forbindelse - 1-cyclohexylethanol Desired compound
4-(1-cyclohexylethoxy)acetanilid Smeltepunkt: 94 - 95° C 4-(1-cyclohexylethoxy)acetanilide Melting point: 94 - 95° C
Elementæranalyse for C^l^-jNC^:Elemental analysis for C^l^-jNC^:
Beregnet: C 73,53 %, H 8,87 %, N 5,36 % Funnet C 73,41 %, H 9,08 %, N 5,30 % Calculated: C 73.53%, H 8.87%, N 5.36% Found C 73.41%, H 9.08%, N 5.30%
Eksemp_el_10Example_el_10
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
1-cyclohexy.l-l-methylethanol 1-cyclohexy.l-l-methylethanol
Ønsket forbindelse Desired connection
4-(1-cyclohexyl-l-methylethoxy)acetanilid Smeltepunkt:. 122 - 123° C 4-(1-cyclohexyl-1-methylethoxy)acetanilide Melting point:. 122 - 123° C
Elementæranalyse for ci7H25N02:Elemental analysis for ci7H25N02:
Beregnet: C 74,14 %, H 9,15 %, N 5,09 % Funnet : C 74,07 %, H 9,41 %, N 4,93 % Calculated: C 74.14%, H 9.15%, N 5.09% Found: C 74.07%, H 9.41%, N 4.93%
Eksemgel_llExemgel_ll
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
l-toenzyl-l-methylethanol l-toenzyl-l-methylethanol
Ønsket forbindelseDesired connection
4- (a ,a-dimet.hylfénethyloxy) acetanilid Smeltepunkt: 153 - 154° C. 4-(α,α-dimeth.hylfénethyloxy)acetanilide Melting point: 153 - 154° C.
Elementæranalyse for C^gH^NC^:Elemental analysis for C^gH^NC^:
Béregnet: C 76,30 %, H 7,47 %, N 4,94 %Calculated: C 76.30%, H 7.47%, N 4.94%
Funnet : C 76,38 H 7,47 %, N 4,91 % Found : C 76.38 H 7.47%, N 4.91%
Eksemp_el_12 Example_el_12
Alkoholforbindelsen anvendt som utgangsmateriale The alcohol compound used as starting material
1-methylcyclohexanoi 1-methylcyclohexanoic
Ønsket forbindelse Desired connection
4-(1-methylcyclohexyloxy)acetanilid 4-(1-methylcyclohexyloxy)acetanilide
Smeltepunkt: 123 - 124° C Elementæranalyse for C^Hj^NC^ :•, Melting point: 123 - 124° C Elemental analysis for C^Hj^NC^ :•,
Beregnet: C 72,84 %, H 8,56 %, N 5,66 %Calculated: C 72.84%, H 8.56%, N 5.66%
.Funnet : C 73,15 %, H 8,65 %, N 5,76 % Eksemp_el_13 Alkoholforbindelse anvendt som utgangsmateriale .Found: C 73.15%, H 8.65%, N 5.76% Example_el_13 Alcohol compound used as starting material
3-methylmenthol Ønsket forbindelse 3-methylmenthol Desired connection
4- ( 3-methyl-p-menthan-3-yloxy)acetanilid Smeltepunkt: 133 134° C 4-(3-methyl-p-menthan-3-yloxy)acetanilide Melting point: 133 134° C
Elementæranalyse for C^gl-^gNC^: Elemental analysis for C^gl-^gNC^:
Beregnet: C 75,21 %, H 9,63 %, N 4,62 %Calculated: C 75.21%, H 9.63%, N 4.62%
Funnet : C 74,69 %, H 9,96 %, N 4,93 % Found : C 74.69%, H 9.96%, N 4.93%
Eksemp_el_14Example_el_14
Alkoholforbindelse som utgangsmateriale 1-cyclohexyl-l-fenylethanol Ønsket forbindelse Alcohol compound as starting material 1-cyclohexyl-l-phenylethanol Desired compound
4- (a-cyclohexyl-ct-methylbenzyloxy) acetanilid. 4-(α-cyclohexyl-ct-methylbenzyloxy)acetanilide.
Smeltepunkt: 102 - 103° CMelting point: 102 - 103° C
Elementæranalyse for C22<H>27NQ2:Elemental analysis for C22<H>27NQ2:
Beregnet: C 78,30%, H 8,06 %, N 4,15 % Funnet : C 78,01 i, H 8,34 %, N 4,36 % Calculated: C 78.30%, H 8.06%, N 4.15% Found: C 78.01%, H 8.34%, N 4.36%
Eksemgel_15Eczema gel_15
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
dicyclohexylmethanol dicyclohexylmethanol
Ønsket forbindelse Desired connection
4-(dicyclohexylmethoxy)acetanilid Smeltepunkt: 187 - 188° C Elementæranalyse forC21<H>31N02:Beregnet: C 76,55 %, H 9,48 %, N 4,25 % Funnet : C 76,61 %, H.9,84 %, N 4,15 % 4-(dicyclohexylmethoxy)acetanilide Melting point: 187 - 188° C Elemental analysis for C21<H>31N02: Calculated: C 76.55%, H 9.48%, N 4.25% Found: C 76.61%, H.9 .84%, N 4.15%
Eksemgel_16Eczema gel_16
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
a,a-dimethylbenzylalkohol. Ønsket forbindelse α,α-dimethylbenzyl alcohol. Desired connection
4-(a,a-dimethylbenzyloxy)acetanilid Smeltepunkt: 130 - 131° C 4-(a,a-dimethylbenzyloxy)acetanilide Melting point: 130 - 131° C
Elementæranalyse for C^H^^NC^:Elemental analysis for C^H^^NC^:
■Beregnet: C 75,81 I, H 7*11 %, N 5,20 % Funnet : C 76,05 %, H 7,18 %, N 5,44 % ■Calculated: C 75.81 I, H 7*11 %, N 5.20 % Found : C 76.05 %, H 7.18 %, N 5.44 %
Eksemp_el_17Example_el_17
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
cyclohexanol Ønsket forbindelse. 4-(cyclohexyloxy)acetanilid Smeltepunkt: 158 - 159° C Elementæranalyse for C^H^NO.,:Beregnet: C 72,07 %, H 8,21 %, N 6,00 % Funnet : C 71,72'%, H 8,30 %, N 6,33 % cyclohexanol Desired compound. 4-(cyclohexyloxy)acetanilide Melting point: 158 - 159° C Elemental analysis for C^H^NO.,:Calculated: C 72.07%, H 8.21%, N 6.00% Found: C 71.72'% , H 8.30%, N 6.33%
Forbindelsene i eksempel 18 og 19 ble fremstilt under The compounds in Examples 18 and 19 were prepared below
anvendelse av isosmørsyreanhydrid eller benzoesyreanhydrid i stedet for eddiksyreanhydrid som anvendt i eksempel 4 . use of isobutyric anhydride or benzoic anhydride instead of acetic anhydride as used in example 4.
Éksemp_el_18Example_el_18
Ønsket forbindelseDesired connection
N-isobutyryl-4-(p-menthan-8-yloxy)anilin N-isobutyryl-4-(p-menthan-8-yloxy)aniline
Smeltepunkt: 127 - 128° C Elementæranalyse for C^qH^NC^: Beregnet: C 75,67 %, H 9,84 %, N 4,41 % Funnet : C 75,54 %, H 10,10 %, N 4,21% Melting point: 127 - 128° C Elemental analysis for C^qH^NC^: Calculated: C 75.67%, H 9.84%, N 4.41% Found: C 75.54%, H 10.10%, N 4.21%
Eksemp_el_19Example_el_19
Ønsket forbindelse Desired connection
4-(p-menthan-8-yloxy)benzanilid 4-(p-Menthan-8-yloxy) benzanilide
Smeltepunkt: 121 - 122° CMelting point: 121 - 122° C
Elementæranalyse for C^<K>^NC^".Elemental analysis for C^<K>^NC^".
Beregnet: C 78,60 %,. H 8,32 %, N 3,98 %Calculated: C 78.60%,. H 8.32%, N 3.98%
Funnet : . C 78,31 %, H 8,46 %, N 3,69 %, Found : . C 78.31%, H 8.46%, N 3.69%,
Eksemgel_20 Eczema gel_20
I 10 ml av en ekvivalent blanding av tetrahydrofuran og pyridin ble oppløst 1 g 4-(p-menthan-8-yloxy)anilin og etter In 10 ml of an equivalent mixture of tetrahydrofuran and pyridine, 1 g of 4-(p-menthan-8-yloxy)aniline was dissolved and after
drApevis tilsetning av 0,65 g cyclohexylcarbonylklorid til løs-ningen under isavkjøling ble blandingen omrørt over natten ved romtemperatur. Reaksjonsblandingen ble heldt over i 60 g is Dropwise addition of 0.65 g of cyclohexylcarbonyl chloride to the solution under ice-cooling, the mixture was stirred overnight at room temperature. The reaction mixture was poured into 60 g of ice
etterfulgt av omrøring i 2 timer, og de utfelte krystaller ble oppsamlet.ved filtrering, vasket med vann og omkrystallisert fra 10 ml e.thanol under dannelse av 1,02 g hvitt krystallinsk N- ;«n cyclohexylcarbonyl-4-(p-menthan-8-yloxy)anilin. followed by stirring for 2 hours, and the precipitated crystals were collected by filtration, washed with water and recrystallized from 10 ml of ethanol to give 1.02 g of white crystalline N-;«n cyclohexylcarbonyl-4-(p-menthane -8-yloxy)aniline.
Smeltepunkt: 171 - 172° C Elementæranalyse f or. (-:23^35N<^2 : Melting point: 171 - 172° C Elemental analysis f or. (-:23^35N<^2 :
Beregnet: C 77,27 %, H 9,87 %, . N 3,92 %Calculated: C 77.27%, H 9.87%, . N 3.92%
Funnet : C 77,27 %, H 10,13 %, N 3,74 % Found : C 77.27%, H 10.13%, N 3.74%
Ved å følge lignende fremgangsmåte som beskrevet i eksempel 20 under anvendelse av cinnamoylklorid, 1-adamantanyl-carbonylklorid eller N,N-dimethylcarbamoylklorid i stedet for cyclohexylcarbonylklorid ifølge eksempel 20, ble forbindelsene angitt i eksempel 21- 23 fremstilt. By following a similar procedure as described in example 20 using cinnamoyl chloride, 1-adamantanyl carbonyl chloride or N,N-dimethylcarbamoyl chloride instead of cyclohexyl carbonyl chloride according to example 20, the compounds indicated in examples 21-23 were prepared.
Eksem p_el_21Eczema p_el_21
Ønsket forbindelseDesired connection
N-cinnamoyl-4-(p-menthan-8-yloxy)anilin N-cinnamoyl-4-(p-menthan-8-yloxy)aniline
Smeltepunkt: 75 - 76° C Melting point: 75 - 76° C
Elementæranalyse for C25H3iN02:Elemental analysis for C25H3iN02:
Beregnet: C 79,54 %, H 8,28 %, N 3,71 % Calculated: C 79.54%, H 8.28%, N 3.71%
Funnet : C 79,31 %, H 8,37 %, N 3,52 % Found : C 79.31%, H 8.37%, N 3.52%
Eksemp_el_22Example_el_22
N-(adamant-l-yl-carbonyl)-4-(p-menthan-8-yloxy)anilin Smeltepunkt: .105 - 106° C N-(adamant-1-yl-carbonyl)-4-(p-menthan-8-yloxy)aniline Melting point: .105 - 106° C
Elementæranalyse for C^H^NO^: Elemental analysis for C^H^NO^:
Beregnet: C 79,19 %, H 9,60 %, N 3,42 %Calculated: C 79.19%, H 9.60%, N 3.42%
Funnet : C 79,32 %, H 9,64 %, N 3,26 % Found : C 79.32%, H 9.64%, N 3.26%
Eksemp_el_23 ..., Example_el_23 ...,
Ønsket forbindelseDesired connection
1- (4-(p-menthan-8-yloxy) f enyl]-3 , 3-d.imethylurea Smeltepunkt: 112 - 114° C 1-(4-(p-menthan-8-yloxy)phenyl]-3,3-dimethylurea Melting point: 112 - 114° C
Elementæranalyse for CigH3o<N>2°2<:>Elemental analysis for CigH3o<N>2°2<:>
Beregnet: C 71,66 %, H 9,50 %, N 8,80Calculated: C 71.66%, H 9.50%, N 8.80
Funnet : C 71,56 %, H 9,81 %, N. 8,65 Found: C 71.56%, H 9.81%, N. 8.65
Ved lignende prosedyre som beskrevet i eksempel 1. men ved anvendelse av andre alkoholforbindelser i stedet for p-men-than-8-ol ifølge eksempel 1, ble anilinderivater erholdt og disse ble omsatt med N,N-dimethylcarbamoylklorid eller 1-adamantanyl-carbonylklorid på lignende måte som beskrevet i eksempel 20 under dannelse av forbindelsene ifølge eksempel 24 - 26. By a similar procedure as described in example 1. but using other alcohol compounds instead of p-menthan-8-ol according to example 1, aniline derivatives were obtained and these were reacted with N,N-dimethylcarbamoyl chloride or 1-adamantanyl carbonyl chloride in a similar manner as described in example 20 while forming the compounds according to examples 24 - 26.
Eksemp_el_24 Example_el_24
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
Ønsket forbindelse Desired connection
1-14-(p-menthan-3-yloxy ).f enyl ]-3 , 3-dimethylurea 1-14-(p-menthan-3-yloxy).phenyl]-3,3-dimethylurea
Smeltepunkt: 154 - 156° CMelting point: 154 - 156° C
Elementæranalyse for c^<gH3>Q<N2>02:Elemental analysis for c^<gH3>Q<N2>02:
Beregnet: C 71,66 %, H 9,50 N 8,80 %Calculated: C 71.66%, H 9.50 N 8.80%
Funnet : C 71, 53 H 9,69 %, N 8,58 Found: C 71, 53 H 9.69%, N 8.58
Eksemp_el_25 Example_el_25
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
Cyclohexylmethanol Ønsket forbindelse Cyclohexylmethanol Desired compound
1-(4-cyclohexylmethoxyfenyl)-3,5-dimethylurea Smeltepunkt: 158 - 159° C 1-(4-cyclohexylmethoxyphenyl)-3,5-dimethylurea Melting point: 158 - 159° C
Elementæranalyse for c1gH24N2°2:Elemental analysis for c1gH24N2°2:
Beregnet: C. 69 ,53 %, H 8,75 %, N 10,14 % Funnet : C 69,21 %, H 8,81 %, N 9,90 % Calculated: C. 69.53%, H 8.75%, N 10.14% Found: C 69.21%, H 8.81%, N 9.90%
Eksemp_e.l 26Example_e.l 26
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
Ønsket forbindelse Desired connection
N-(adamant-l-ylcarbonyl)-4-(p-menthan-3-yloxy)anilin N-(adamant-1-ylcarbonyl)-4-(p-menthan-3-yloxy)aniline
Smeltepunkt: 194 - 195° C Melting point: 194 - 195° C
Elementæranalyse for C27H39N02:Elemental analysis for C27H39N02:
Beregnet: C 79,17 %, H 9,60 %, N 3,42 %Calculated: C 79.17%, H 9.60%, N 3.42%
Funnet : C 79,40 %, H 9,86 %, N 3,37 % Found : C 79.40%, H 9.86%, N 3.37%
Eksemp_el_2 7Example_el_2 7
I 10 ml vannfri tetrahydrofuran ble oppløst 2,0 g-4-(p-. menthan-8-yloxy)anilin og etter tilsetning av 5 ml vannfri pyridin ble 1,55 g N-decanoylklorid (CgH19COCl) dråpevis tilsatt til blandingen under isavkjøling og den resulterende blanding ble om-rørt over natten ved romtemperatur. In 10 ml of anhydrous tetrahydrofuran, 2.0 g of 4-(p-.menthan-8-yloxy)aniline was dissolved and after the addition of 5 ml of anhydrous pyridine, 1.55 g of N-decanoyl chloride (CgH19COCl) was added dropwise to the mixture under ice-cooling and the resulting mixture was stirred overnight at room temperature.
Reaksjonsblandingen ble heldt over 50 g is fulgt av omrøring i 3 timer. Det således utfelte oljeaktige produkt ble deretter gjenvunnet ved dekantering og oppløst i 100 ml ether. Etherløsningen ble vasket suksessivt med 3 % saltsyre, en mettet t vannfri natriumhydrogencarbonatløsning, og derettér en vandig natriumkloridløsning, tørket med vannfritt natriumsulfat hvoretter løsningsmidlet ble destillert fra under redusert trykk under dannelse av 3,2 g krystaller av 4-(p-menthan-8-yloxy)-N-decanoylanilin. Ved omkrystallisering av produktet fra ethanol ble hvite krystaller med et smeltepunkt på 31 - 32° C erholdt. The reaction mixture was poured over 50 g of ice followed by stirring for 3 hours. The thus precipitated oily product was then recovered by decantation and dissolved in 100 ml of ether. The ether solution was washed successively with 3% hydrochloric acid, a saturated t anhydrous sodium bicarbonate solution, and then an aqueous sodium chloride solution, dried with anhydrous sodium sulfate after which the solvent was distilled off under reduced pressure to form 3.2 g of crystals of 4-(p-menthan-8 -yloxy)-N-decanoylaniline. On recrystallization of the product from ethanol, white crystals with a melting point of 31 - 32° C were obtained.
Elementæranalyse for C2gH^2N02:Elemental analysis for C2gH^2N02:
Beregnet: C 77,75 %, H 10,79 %, N 3,49 %Calculated: C 77.75%, H 10.79%, N 3.49%
Funnet C 77,55 %, H 11,07 %, N 3,41 % Found C 77.55%, H 11.07%, N 3.41%
Eksemp_el_28'Example_el_28'
Ved å følge samme prosedyre som beskrevet i eksempel 27 under anvendelse av myristoylklorid • ( C-^^ Hi stedet for N-decanoylklorid, ble 4-(p-rnenthan-8-ylo.xy)-N-myristoylanilin erholdt-.... By following the same procedure as described in Example 27 using myristoyl chloride • ( C-^^ Hi instead of N-decanoyl chloride, 4-(p-rnenthan-8-yloxy)-N-myristoylaniline was obtained-... .
Smeltepunkt: 51 52° CMelting point: 51 52° C
Elementæranalyse for C^gH^NC^:Elemental analysis for C^gH^NC^:
Beregnet: C 78,72 %, H 11,23 %, N 3,06 % Funnet : C 78,54%, H 11,56 % , N 2,90 Eksemp_el_29 Calculated: C 78.72%, H 11.23%, N 3.06% Found: C 78.54%, H 11.56% , N 2.90 Example_el_29
Ved å følge samme prosedyre som beskrevet i eksempel -<27 under anvendelse av palmitoylklorid (C-^H^COCl) i stedet for N-decanoylklorid, ble 4-(p-menthan-8-yloxy)-N-palmitoylanilin erholdt. By following the same procedure as described in Example -<27 using palmitoyl chloride (C-^H^COCl) instead of N-decanoyl chloride, 4-(p-menthan-8-yloxy)-N-palmitoylaniline was obtained.
Smeltepunkt: 61 - 62° CMelting point: 61 - 62° C
Elementæranalyse for C32H55N02:Elemental analysis for C32H55N02:
Beregnet: C 79,12 %, H 11,41 %, N2,88 %Calculated: C 79.12%, H 11.41%, N2.88%
Funnet : C 79,45 %, H 11,79 %, N 2,71 % Found : C 79.45%, H 11.79%, N 2.71%
Eksemp_el_3 0 Example_el_3 0
I 20 ml vannfri tetrahydrofuran ble 2,0 g 4-(p-menthan-8-yloxy)anilin og 4,5 g vannfri stearinsyre suspendert og etter dråpevis tilsetning av 5 ml vannfri pyridin under omrøring og is-avkjøling ble blandingen omrørt over natten ved romtemperatur. In 20 ml of anhydrous tetrahydrofuran, 2.0 g of 4-(p-menthan-8-yloxy)aniline and 4.5 g of anhydrous stearic acid were suspended and after the dropwise addition of 5 ml of anhydrous pyridine while stirring and ice-cooling, the mixture was stirred overnight at room temperature.
Reaksjonsblandingen ble heldt over .100 g is etterfulgt av omrøring i 2 timer og utfelte hvite krystaller ble oppsamlet The reaction mixture was poured over .100 g of ice followed by stirring for 2 hours and precipitated white crystals were collected
ved filtrering, vasket tre ganger hver gang med 50 ml petrol-ether, og deretter omkrystallisert to ganger med 25 ml ethanol under dannelse av 3,1 g hvite krystaller av 4-(p-menthan-8-yloxy)-N-stearoylanilin. by filtration, washed three times each time with 50 ml of petroleum ether, and then recrystallized twice with 25 ml of ethanol to give 3.1 g of white crystals of 4-(p-menthan-8-yloxy)-N-stearoylaniline.
Smeltepunkt: 72 - 73° CMelting point: 72 - 73° C
Elementæranalyse for C^Hj-gNC^: tiElemental analysis for C^Hj-gNC^: ti
Beregnet: C 79,47 %, H 11,57 %, N 2,73 %Calculated: C 79.47%, H 11.57%, N 2.73%
Funnet : C 7 9,71 %, H 11,93 %, N 2,44 % Found : C 7 9.71%, H 11.93%, N 2.44%
Eksemgel_31 Eczema gel_31
Til 150 ml vannfri ethanol ble tilsatt 6,2 g 4-(p-menthan-8-yloxy)anilin, 7 g vannfri kalium carbonat og 5,75 g 1,5-dibrompentan, og blandingen ble kokt under tilbakeløp i 40 timer. Etter avkjøling av reaksjonsblandingen ble løsningsmidlet destillert fra under redusert trykk og til. residuet ble tilsatt 200 ml diklormethan og 150 ml vann. Diklormethanlaget ble fraskilt og. vasket med vann og deretter med en vandig natriumklorid-løsning og tørket over vannfritt natriumsulfat. Løsningsmidlet ble destillert fra under redusert trykk og residuet ble anbragt på en silicagelkolonne. Detønskede produkt ble deretter eluert under anvendelse av benzen mettet med ammoniakk og løsningsmidlet ble deretter destillert fra under redusert trykk fra eluatet under dannelse av 5,77 g krystallinsk 1-[4-(p-menthan-8-yloxy)fenyl]-piperdin. Når produktet ble omkrystailisert fra ethanol ble hvite krystaller med et smeltepunkt på 53 - 54° C erholdt.. To 150 ml of anhydrous ethanol were added 6.2 g of 4-(p-menthan-8-yloxy)aniline, 7 g of anhydrous potassium carbonate and 5.75 g of 1,5-dibromopentane, and the mixture was refluxed for 40 hours. After cooling the reaction mixture, the solvent was distilled from under reduced pressure until to the residue was added 200 ml of dichloromethane and 150 ml of water. The dichloromethane layer was separated and. washed with water and then with an aqueous sodium chloride solution and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure and the residue was applied to a silica gel column. The desired product was then eluted using benzene saturated with ammonia and the solvent was then distilled off under reduced pressure from the eluate to give 5.77 g of crystalline 1-[4-(p-menthan-8-yloxy)phenyl]-piperidine. When the product was recrystallized from ethanol, white crystals with a melting point of 53 - 54° C were obtained.
Elementæranalyse for C2^<H>32N0:Elemental analysis for C2^<H>32N0:
Beregnet: C 79,95 I, H 10,54 %, N 4,44 %Calculated: C 79.95 I, H 10.54%, N 4.44%
Funnet : C 79,50 %, H 10,83 N 4,37 % Found : C 79.50%, H 10.83 N 4.37%
Ved lignende fremgangsmåte som beskrevet i eksempel 1 men ved anvendelse av andre alkoholforbindelser i stedet for p-menthan-8-ol ifølge eksempel 1, ble anilinderivater erholdt, og disse ble omsatt med 1,5-dibrompentan på lignende måte som beskrevet i eksempel 31 under dannelse av forbindelsene ifølge eksemp-lene 32-46.- By a similar procedure as described in example 1 but using other alcohol compounds instead of p-menthan-8-ol according to example 1, aniline derivatives were obtained, and these were reacted with 1,5-dibromopentane in a similar way as described in example 31 while forming the compounds according to examples 32-46.-
Eksemp_el_32Example_el_32
Alkoholforbindelse anvendt som utgangsmaterialeAlcohol compound used as starting material
Ønsket forbindelse Desired connection
1-[4-(p-menthan-3-yloxy)-fenyl]-piperidin 1-[4-(p-Menthan-3-yloxy)-phenyl]-piperidine
Smeltepunkt: 93 - 94° C Elementæranalyse for C21H33NO: Melting point: 93 - 94° C Elemental analysis for C21H33NO:
Beregnet: C 79,95 %, H 10,54 %, N 4,44 %Calculated: C 79.95%, H 10.54%, N 4.44%
Funnet' : C 79,91 %, H 10,75 i, N 4,41 % Found' : C 79.91%, H 10.75 in, N 4.41%
Eksemp_el_33Example_el_33
Alkoholforbindelse anvendt som utgangsmaterialeAlcohol compound used as starting material
3,7-dimethyl-7-octen-l-ol , 3,7-dimethyl-7-octen-l-ol,
Ønsket forbindelseDesired connection
1-[4-(3,7-dimethyloctyloxy)fenyl]piperidin Kokepunkt: .174 - 178°C/0,4 mmHg 1-[4-(3,7-dimethyloctyloxy)phenyl]piperidine Boiling point: .174 - 178°C/0.4 mmHg
Elementæranalyse for C2-LH35NO:Elemental analysis for C2-LH35NO:
Beregnet: C 79,44 %, H 11,11 %, N 4,41 % Funnet : C 79,40 H 11,43 %, N 4,19 % Calculated: C 79.44%, H 11.11%, N 4.41% Found: C 79.40 H 11.43%, N 4.19%
Eksemp_el_34Example_el_34
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
3,7-dimethyl-3-oxy-l,6-octadien 3,7-dimethyl-3-oxy-1,6-octadiene
Ønsket forbindelse Desired connection
N- [4-(3,7-dimethyloct-3-yloxy)fenyl]piperidin Kokepunkt: 174 - 176°C/0,5 mmHg Elementæranalyse for (-21H3 5N<^): Beregnet: C 79,44 %, H 11,11 %, N 4,41 % Funnet : C 79,74 %, H 11,23 %, N 4,13 % N- [4-(3,7-dimethyloct-3-yloxy)phenyl]piperidine Boiling point: 174 - 176°C/0.5 mmHg Elemental analysis for (-21H3 5N<^): Calculated: C 79.44%, H 11.11%, N 4.41% Found : C 79.74%, H 11.23%, N 4.13%
Eksemp_el_3 5Example_el_3 5
Alkoholforbindelse anvendt som utgangsmateriale CH3(CH2)1?-0H Alcohol compound used as starting material CH3(CH2)1?-OH
OctadecanolOctadecanol
Ønsket forbindelseDesired connection
N- ( 4-octadecanyloxyfenyl)piperidin Smeltepunkt: 54 - 55° C. N-(4-octadecanyloxyphenyl)piperidine Melting point: 54 - 55° C.
Elementæranalyse for C^H^NO:Elemental analysis for C^H^NO:
Beregnet: C 81,06'%, H 11,96 %, N 3,26 % Funnet : C 80, 92- %, H 12, 27 %, N 3,00 % Eksemp_el_36 Alkoholforbindelse anvendt som utgangsmateriale Calculated: C 81.06%, H 11.96%, N 3.26% Found: C 80.92%, H 12.27%, N 3.00% Example_el_36 Alcohol compound used as starting material
1,1-dimethylpropanol Ønsket forbindelse. 1,1-dimethylpropanol Desired compound.
N-[4-(1,1-dimethylpropoxy)fenyl]piperidin N-[4-(1,1-dimethylpropoxy)phenyl]piperidine
Kokepunkt: 120. - 122°C/1 mmHgBoiling point: 120. - 122°C/1 mmHg
Elementæranalyse for C-^gH^NO:Elemental analysis for C-^gH^NO:
Beregnet: C 77,68%, H 10,19 %, N 5,66 %Calculated: C 77.68%, H 10.19%, N 5.66%
Funnet : C 77,32 %, H 10,24 %, N 5,39 % Found : C 77.32%, H 10.24%, N 5.39%
Eksemgel_37 Eczema gel_37
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
Cyclohexylmethanol Ønsket forbindelse Cyclohexylmethanol Desired compound
N-[4-(cyclohexylmethoxy)fenyl]piperidin Smeltepunkt: 63 - 64° C N-[4-(cyclohexylmethoxy)phenyl]piperidine Melting point: 63 - 64° C
Elementæranalyse for C^g<H>27NO:Elemental analysis for C^g<H>27NO:
Beregnet: C 79,07 %, H 9,95 %, N 5,12 % Funnet : C 78,88 %, H 10,22 %, N 5,00 % Calculated: C 79.07%, H 9.95%, N 5.12% Found: C 78.88%, H 10.22%, N 5.00%
Eksemp_el_38Example_el_38
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
1-cyclohexylethanol Ønsket forbindelse 1-cyclohexylethanol Desired compound
N- [4-(1-cyclohexylethoxy)fenyl]piperidin N-[4-(1-cyclohexylethoxy)phenyl]piperidine
Kokepunkt: 147 - 148°C/0,3 mmHgBoiling point: 147 - 148°C/0.3 mmHg
Elementæranalyse for C^gh^gNO: Beregnet: C 79,39 %, H 10,17 %, N 4,87 % Funnet : C 79,28 %, H 10,51 %, N 4,87 % Elemental analysis for C^gh^gNO: Calculated: C 79.39%, H 10.17%, N 4.87% Found: C 79.28%, H 10.51%, N 4.87%
Eksemp_el_39 Example_el_39
Alkoholforbindelse anvendt som utgangsmaterialeAlcohol compound used as starting material
1-cyclohexyl-i-methylethanol Ønsket forbindelse 1-cyclohexyl-i-methylethanol Desired compound
N-[4-(1-cyclohexyl-l-methylethoxy)fenyl]piperidin N-[4-(1-cyclohexyl-1-methylethoxy)phenyl]piperidine
Smeltepunkt: 66 - 67° CMelting point: 66 - 67° C
Elementæranalyse for C2qH^NO:Elemental analysis for C2qH^NO:
Beregnet: C 79,68 %, H 10,36 %, N 4,65 %Calculated: C 79.68%, H 10.36%, N 4.65%
Funnet : C 79,54 %, H 10,58 %, N 4,41 % Found : C 79.54%, H 10.58%, N 4.41%
Eksemgel 4 0Exemgel 4 0
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
1-benzyl-l-methyléthanol Ønkset forbindelse 1-benzyl-1-methylethanol Desired compound
N- [4-(a,a-dimethylfenethyloxy)fenyl]piperidin N-[4-(α,α-dimethylphenethyloxy)phenyl]piperidine
Smeltepunkt: 68. - 69° C Elementæranalyse for C21H27NO: Melting point: 68. - 69° C Elemental analysis for C21H27NO:
Beregnet: C 81,51 %, H 8,79 %, N 4,53 %Calculated: C 81.51%, H 8.79%, N 4.53%
Funnet : C 81,33 %, H 8,95 %, N 4,52 % Found : C 81.33%, H 8.95%, N 4.52%
Eksempel_41Example_41
Alkoholforbindelse anvendt som utgangsmaterialeAlcohol compound used as starting material
1-methylcyclohexanol. 1-methylcyclohexanol.
Ønsket forbindelseDesired connection
N-[4-(1-methylcyclohexyloxy)fenyl]-piperidin-hydroklorid Smeltepunkt:. 150 - 151° C N-[4-(1-methylcyclohexyloxy)phenyl]-piperidine hydrochloride Melting point:. 150 - 151° C
Elementæranalyse for C^gH2gNOCl:Elemental analysis for C^gH2gNOCl:
Beregnet: C 69,77 %, H 9,1.1 %, N 4,52 %Calculated: C 69.77%, H 9.1.1%, N 4.52%
Funnet : C 69,39 %, H 9,42 %, N 4,64 % Found : C 69.39%, H 9.42%, N 4.64%
Eksemgel_42Eczema gel_42
Alkoholforbindelse anvendt som utgangsmaterialeAlcohol compound used as starting material
3-methylmenthol . ; Ønsket forbindelse 3-Methylmenthol. ; Desired connection
N-[4-(3-methyl-p-menthan-3-yloxy)fenyl]piperidin Kokepunkt: 140 - 145°C/0,3 mmH N-[4-(3-methyl-p-menthan-3-yloxy)phenyl]piperidine Boiling point: 140 - 145°C/0.3 mmH
Elementæranalyse for £22^ 25®®"'Elementary analysis for £22^ 25®®"'
Beregnet: C 80,19 %, H 10,71 %, N 4,25 % Funnet : C 80,14 %, H 10,42 %, N 3,92 % Calculated: C 80.19%, H 10.71%, N 4.25% Found: C 80.14%, H 10.42%, N 3.92%
Eksemp_el_43 Example_el_43
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
a-cyclohexyl-a-methylbenzylalkohol Ønsket forbindelse. α-cyclohexyl-α-methylbenzyl alcohol Desired compound.
N-[4-(a-cyclohexyl-a-methylbenzyloxy)fenyl]piperidin Kokepunkt: 178 - 183°C/0,25 mmH N-[4-(a-cyclohexyl-a-methylbenzyloxy)phenyl]piperidine Boiling point: 178 - 183°C/0.25 mmH
Elementæranalyse for € 2^ 22^''Elemental analysis for € 2^ 22^''
Beregnet: C 82,60 %, H 9,15 %, N 3,85 %Calculated: C 82.60%, H 9.15%, N 3.85%
Funnet : C 82,66 %, H 9,35 %, N 3,65 % Found : C 82.66%, H 9.35%, N 3.65%
Eksemp_el_44Example_el_44
Alkoholforbindelse anvendt som utgangsmateriale dicyclohexylmethanol Ønsket forbindelse Alcohol compound used as starting material dicyclohexylmethanol Desired compound
N-(4-dicyclohexylmethoxyfenyl)piperidin Smeltepunkt: 57 - 58° C N-(4-dicyclohexylmethoxyphenyl)piperidine Melting point: 57 - 58° C
Elementæranalyse for C^^ H^- j^ 1Elemental analysis for C^^ H^- j^ 1
Beregnet: C 81,07 %, H 10,49 %, N 3,94 % Funnet : C 81,16 %, H 10,83 %, N 3,75 % Calculated: C 81.07%, H 10.49%, N 3.94% Found: C 81.16%, H 10.83%, N 3.75%
Eksemp_el_45 Example_el_45
Alkoholforbindelse.anvendt som utgangsmateriale Alcohol compound.used as starting material
a,a-dimethylbenzylalkohol Ønsket forbindelse α,α-dimethylbenzyl alcohol Desired compound
N-[4-(a,a-dimethylbenzyloxy)fenyl]piperidin Smeltepunkt: 92 - 93° C N-[4-(a,a-dimethylbenzyloxy)phenyl]piperidine Melting point: 92 - 93° C
Elementæranalyse for C2QH25NO:Elemental analysis for C2QH25NO:
Beregnet: C 81,31 %, H 8,53 %, N 4,74 % Funnet : C 81,09 %, H 9,69 %, N 4,98 % Calculated: C 81.31%, H 8.53%, N 4.74% Found: C 81.09%, H 9.69%, N 4.98%
Eksemp_el_46Example_el_46
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
cyclohexanol Ønsket forbindelse . cyclohexanol Desired compound .
N-(4-cyclohexyloxyfenyl)piperidin N-(4-cyclohexyloxyphenyl)piperidine
Smeltepunkt: 50 - 51° C Melting point: 50 - 51° C
Elementæranalyse for C^7H2^NO:Elemental analysis for C^7H2^NO:
Beregnet: C 78,72%, H 9,71 I, N 5,40% Calculated: C 78.72%, H 9.71 I, N 5.40%
Funnet : C 78,51 %, H 9,92 %, N 5,56 % Found : C 78.51%, H 9.92%, N 5.56%
Eksemp_el_4 7Example_el_4 7
Til 50 ml vannfri ethanol ble tilsatt 1,23 g 4-(p-menthan-8-yloxy)anilin, 1,4 g vannfri kaliumcarbonat og 1,1 g 1,4-dibrombutan og blandingen ble kokt under tilbakeløpskjøling i 42 timer. Deretter ble reaksjonsproduktet underkastet ekstraksjon og rensing som beskrevet i eksempel 31.under dannelse av 1,1 ,g krystallinsk N-[4-(p-menthan-8-yloxy)fenyl]pyrrolidin. To 50 ml of anhydrous ethanol was added 1.23 g of 4-(p-menthan-8-yloxy)aniline, 1.4 g of anhydrous potassium carbonate and 1.1 g of 1,4-dibromobutane and the mixture was boiled under reflux for 42 hours. The reaction product was then subjected to extraction and purification as described in example 31, forming 1.1 g of crystalline N-[4-(p-menthan-8-yloxy)phenyl]pyrrolidine.
Når produktet ble omkrystallisert fra ethanol ble det erholdt hvite krystaller med smeltepunkt på 92 - 93° C. When the product was recrystallized from ethanol, white crystals with a melting point of 92 - 93° C were obtained.
Elementæranalyse for C2qH.^NO:Elemental analysis for C2qH.^NO:
Beregnet: C 79,68 %, H 10,36 %, N 4,65 %Calculated: C 79.68%, H 10.36%, N 4.65%
Funnet : C 79,43 %, II 10,65 %, N 4,37 % Found : C 79.43%, II 10.65%, N 4.37%
Eksemp_el_48 Example_el_48
Til 150 ml vannfri ethanol ble tilsatt 30 g cis-4-(p- menthan-8-yloxy)anilin, 25,2 g vannfri kaliumcarbonat og.33,5 g 1,5-dibrompentan og blandingen ble kokt under tilbakeløpskjøling 30 g of cis-4-(p-menthan-8-yloxy)aniline, 25.2 g of anhydrous potassium carbonate and 33.5 g of 1,5-dibromopentane were added to 150 ml of anhydrous ethanol and the mixture was boiled under reflux
i 15 timer. Etter avkjøling av reaks jonsblandingen ble løsnings-midlet destillert fra under redusert trykk og til residuet ble tilsatt 5.00 ml diklormethan og 500 ml vann. Diklormethanlaget ble fraskilt ved dekantering, vasket med vann og deretter med en vandig natriumkloridløsning, og tørket over vannfritt natriumsulfat. Løsningsmidlet ble destillert fra under redusert trykk for 15 hours. After cooling the reaction mixture, the solvent was distilled off under reduced pressure and 5.00 ml of dichloromethane and 500 ml of water were added to the residue. The dichloromethane layer was separated by decantation, washed with water and then with an aqueous sodium chloride solution, and dried over anhydrous sodium sulfate. The solvent was distilled from under reduced pressure
og det dannede residuum ble overført til en silicagelkolonne.and the residue formed was transferred to a silica gel column.
Detønskede produkt ble deretter eluert under anvendelse av ben-The desired product was then eluted using ben-
zen mettet med ammoniakk, og løsningsmidlet i eluatet ble destillert fra under redusert trykk under dannelse av 23 g cis-l-[4-(p-menthan-8-yloxy)fenyl]piperidin. Når produktet ble omkrystalli-s.ert fra ethanol ble det erholdt hvite krystaller med smeltepunkt på 78 - 79° C. ■ zen saturated with ammonia, and the solvent in the eluate was distilled off under reduced pressure to give 23 g of cis-1-[4-(p-menthan-8-yloxy)phenyl]piperidine. When the product was recrystallized from ethanol, white crystals with a melting point of 78 - 79° C were obtained. ■
Elementæranalyse for C22H33NO:Elemental analysis for C22H33NO:
Beregnet: C 7 9,95 %, H 10,54 1, N 4,44 ICalculated: C 7 9.95%, H 10.54 1, N 4.44 I
Funnet : C 79,83 %, H 10,98 %, N 4,36 % Found : C 79.83%, H 10.98%, N 4.36%
Eksempel 49Example 49
—————— i —————— i
Ved å følge samme prosedyre som beskrevet i eksempel 4 8 ved anvendelse av trans-4-(p-menthan-8-yloxy)aniiin i stedet for'cis-4-(p-menthan-8-yloxy)anilin ble det erholdt krystaller av trans-1-[4-(p-menthan-8-yloxy)fenyl]piperidin. By following the same procedure as described in Example 4 8 using trans-4-(p-menthan-8-yloxy)aniline instead of cis-4-(p-menthan-8-yloxy)aniline, crystals were obtained of trans-1-[4-(p-menthan-8-yloxy)phenyl]piperidine.
Smeltepunkt: 62 - 63° CMelting point: 62 - 63° C
Elementæranalyse for ^I^^^CmElemental analysis for ^I^^^Cm
Beregnet: C 79, 95 l, I-l 10,54 %, N 4,44 %Calculated: C 79, 95 l, I-l 10.54%, N 4.44%
Funnet C 80,00 %, H 10,87 %, N 4 , 39 % ?h§S2E§I_å5 Found C 80.00%, H 10.87%, N 4 , 39% ?h§S2E§I_å5
I 47 ral av en 95 %-ig ethanolløsning på 1 normal kaliumhydroxyd ble oppløst 2,1 g trans-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)anilin og løsningen ble kokt under tilbakeløps-kjøling i 6 timer. Deretter ble ethanolen destillert fra under redusert trykk fra reaksjonsblandingen og til det dannede residuum ble tilsatt 50 ml ether og 50 ml vann etterfulgt av ekstraksjon In 47 ral of a 95% ethanol solution of 1 normal potassium hydroxide, 2.1 g of trans-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)aniline were dissolved and the solution was boiled under reflux for 6 hours. Then the ethanol was distilled from under reduced pressure from the reaction mixture and to the residue formed 50 ml of ether and 50 ml of water were added followed by extraction
med ether. Ekstraktet ble vasket med vann og deretter med én with ether. The extract was washed with water and then with one
vandig natriumkloridløsning og etter tørking over vannfritt magnesiumsulfat ble etheren destillert fra reaksjonsblandingen under dannelse av 1,7.5 g trans-4-(p-menthan-8-yloxy) anilin. aqueous sodium chloride solution and after drying over anhydrous magnesium sulfate, the ether was distilled from the reaction mixture to give 1.7.5 g of trans-4-(p-menthan-8-yloxy) aniline.
Til 50 ml vannfritt ethanol ble tilsatt 1,7 g av produktet sammen med 2 g Vannfritt kaliumcarbonat og 1,7 g 1,5-dibrompentan og blandingen ble kokt under tilbakeløpskjøling i 16 timer... Ved behandling av reaksjonsproduktet som beskrevet i eksempel 48, ble 0,95 g krystaller av trans-1-[4-(p-menthan-8-yloxy)fenyl)-piperidin erholdt. To 50 ml of anhydrous ethanol was added 1.7 g of the product together with 2 g of anhydrous potassium carbonate and 1.7 g of 1,5-dibromopentane and the mixture was boiled under reflux for 16 hours... When treating the reaction product as described in example 48 , 0.95 g of crystals of trans-1-[4-(p-menthan-8-yloxy)phenyl)-piperidine were obtained.
Smeltepunkt: 62 - 63° C. Melting point: 62 - 63° C.
Infrarød absorpsjonsspektra, kjernemagnetisk resonansspektrum ("'"H, "^C), og massespektrum av krystallene stemte godt. overens med spektra for krystallene erholdt i eksempel 49. Infrared absorption spectra, nuclear magnetic resonance spectrum ("'"H, "^C), and mass spectrum of the crystals were in good agreement with the spectra of the crystals obtained in Example 49.
Eksemgel_51Eczema gel_51
Ved å følge samme prosedyre som beskrevet i eksempel 50 under anvendelse av cis-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)-anilin i stedet for trans-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)-anilin, ble krystaller av cis-1-[4-(p-menthan-8-yloxy)fenyl]-piperidin erholdt. By following the same procedure as described in Example 50 using cis-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)-aniline instead of trans-N-ethoxycarbonyl-4-(p-menthan-8- yloxy)-aniline, crystals of cis-1-[4-(p-menthan-8-yloxy)phenyl]-piperidine were obtained.
Smeltepunkt: 78 79° C.Melting point: 78 79° C.
Det infrarøde absorpsjonsspektrum, k jerneimagnetiskeThe infrared absorption spectrum, k nuclear magnetic
1 12 resbnansspektr.um ( H, C), og massespektrum av krystallene stemte overens med de for krystaller erholdt i eksempel 48. 1 12 response spectrum (H, C), and mass spectrum of the crystals agreed with those for crystals obtained in example 48.
Eksemp_el_52Example_el_52
Til 100 ml vannfri ethanol ble suksessivt tilsatt 2,5 g 4-(p-menthan-8-yloxy)anilin, 1,4 g vannfritt kaliumcarbonat og 1,7 g benzylbromid, og etter omsetning i 4 timer ved romtemperatur ble blandingen deretter kokt under tilbakeløpskjøling i 40 timer. Reaksjonsblandingen ble deretter underkastet ekstraksjon og renset som beskrevet i eksempel 31 under dannelse av 0,95 g oljeaktig N-benzyl-4-(p-menthan-8-yloxy)-anilin. Produktet ble oppløst i 25 ml ..vannfri; ether, og etter tilsetning av 1 ml 5 normal saltsyre under, avkjøling, ble blandingen avkjølt under dan-neise av 0,8 g hydroklorid av N-berizyl-4-(p-menthan-8-yloxy)-anilin. Når hydrokloridproduktet ble omkrystallisert fra en blanding av diklormethan og ethylacetat ble det erholdt hvite krystaller med ét smeltepunkt på 137 - 138° C. To 100 ml of anhydrous ethanol, 2.5 g of 4-(p-menthan-8-yloxy)aniline, 1.4 g of anhydrous potassium carbonate and 1.7 g of benzyl bromide were successively added, and after reaction for 4 hours at room temperature, the mixture was then boiled under reflux for 40 hours. The reaction mixture was then subjected to extraction and purification as described in Example 31 to yield 0.95 g of oily N-benzyl-4-(p-menthan-8-yloxy)-aniline. The product was dissolved in 25 ml ..anhydrous; ether, and after adding 1 ml of 5 normal hydrochloric acid under cooling, the mixture was cooled to give 0.8 g of N-berizyl-4-(p-menthan-8-yloxy)-aniline hydrochloride. When the hydrochloride product was recrystallized from a mixture of dichloromethane and ethyl acetate, white crystals with a melting point of 137 - 138° C were obtained.
Elementæranalyse for C22H3 2N(-)C1:Elemental analysis for C22H3 2N(-)C1:
Beregnet: C 73 , 87 %', . H 8 , 63 N 3,75%Calculated: C 73 , 87%', . H 8 , 63 N 3.75%
Funnet : C 7 3,55 %, H 8,72 %, N 3,54 % Found : C 7 3.55%, H 8.72%, N 3.54%
Eksemp_el_53 Example_el_53
Ved å følge samme prosedyre som beskrevet i eksempel 52 under anvendelse av 1-brombutan i stedet,for benzylbromid, ble N-butyl-4-(p-menthan-8-yloxy)anilin.hydroklorid erholdt. By following the same procedure as described in Example 52 using 1-bromobutane instead of benzyl bromide, N-butyl-4-(p-menthan-8-yloxy)aniline hydrochloride was obtained.
Smeltepunkt: 138 - 139° CMelting point: 138 - 139° C
Elementæranalyse for C2qH34NOC1:Elemental analysis for C2qH34NOC1:
Beregnet: C 7 0,66 %, H 10,08 %, N 4,12 %Calculated: C 7 0.66%, H 10.08%, N 4.12%
Funnet : C 70,46%, H 10,28%, N 3,91 % Found : C 70.46%, H 10.28%, N 3.91%
Eksemgel_54 Eczema gel_54
I 50 ml vannfri pyridin ble oppløst 5 g 4-(p-menthan-8-yloxy)anilin og deretter ble 4 ml ethylklorcarbonat dråpevis tilsatt til løsningen under omrøring og isavkjøling. Etter ytterligere omrøring av blandingen over natten ved 4° C, ble reaksjonsblandingen heldt over i 300 ml isvann og det dannede oljeaktige produkt ble ekstrahert med ether. Ekstraktet ble vasket suksessivt med vann, 2 %-ig saltsyre, vann og deretter en vandig natriumkloridløsning og tørket over vannfritt magnesiumsulfat. 5 g of 4-(p-menthan-8-yloxy)aniline was dissolved in 50 ml of anhydrous pyridine and then 4 ml of ethyl chlorocarbonate was added dropwise to the solution with stirring and ice-cooling. After further stirring the mixture overnight at 4°C, the reaction mixture was poured into 300 ml of ice water and the oily product formed was extracted with ether. The extract was washed successively with water, 2% hydrochloric acid, water and then an aqueous sodium chloride solution and dried over anhydrous magnesium sulfate.
Løsningsmidlet ble destillert fra under redusert trykk og de dannede .krystaller ble omkrystallisert fra 20 ml methanol under dannelse av.. 3,5 g hvitt krystallinsk N-ethoxycarbonyl-4-(p-menthan-8-yToxy ) anilin.. The solvent was distilled off under reduced pressure and the crystals formed were recrystallized from 20 ml of methanol to give 3.5 g of white crystalline N-ethoxycarbonyl-4-(p-menthan-8-yToxy) aniline.
Smeltepunkt 65 - 66° CMelting point 65 - 66° C
Elementæranalyse for C^H^NO^".Elemental analysis for C^H^NO^".
Beregnet: C 71,44 %, H 9,15 %, H 4,38 %Calculated: C 71.44%, H 9.15%, H 4.38%
Funnet : C 71,46 %, H 9,37 %, H 4 , 54 Found : C 71.46%, H 9.37%, H 4 , 54
Fra omkrystallisering av moderluten ble i tillegg 1,5From recrystallization of the mother liquor was additionally 1.5
g åv det ønskede produkt erholdt.g of the desired product obtained.
£!S§ÉfI!Bei 55£!S§ÉfI!Bei 55
I en blanding av 40 ml vannfri pyridin og 100 ml vannfri diklormethan ble løst 21 g trans-4-(p-menthan-8-yloxy)anilin hvoretter 18,5 g' ethylklorcarbonat dråpevis ble tilsatt løsningen under omrøring og isavkjøling. Etter ytterligere omrøring av blandingen over natten ved 4° C ble reaksjonsblandingen heldt over i 300 ml is-vann og det dannede diklormethanlag ble gjenvunnet. Det vandige lag ble re-ekstrahert med 8 0 ml diklormethan og ekstraktet ble kombinert med diklormethanløsningen gjenvunnet tidligere, og blandingen ble vasket suksessivt med vann, 2 %-ig saltsyre, vann og deretter en vandig natriumkloridløsning og ,,( tørket over vannfritt magnesiumsulfat. Løsnigsmidlet ble der- In a mixture of 40 ml of anhydrous pyridine and 100 ml of anhydrous dichloromethane, 21 g of trans-4-(p-menthan-8-yloxy)aniline were dissolved, after which 18.5 g of ethyl chlorocarbonate were added dropwise to the solution with stirring and ice-cooling. After further stirring the mixture overnight at 4° C., the reaction mixture was poured into 300 ml of ice-water and the formed dichloromethane layer was recovered. The aqueous layer was re-extracted with 80 ml of dichloromethane and the extract was combined with the dichloromethane solution recovered earlier, and the mixture was washed successively with water, 2% hydrochloric acid, water and then an aqueous sodium chloride solution and,,( dried over anhydrous magnesium sulfate. The solvent was there-
etter destillert fra under redusert trykk og de dannede krystaller ble omkrystallisert fra 80 ml methanol under dannelse av 19,5 g trans-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)anilin. after distilled from under reduced pressure and the crystals formed were recrystallized from 80 ml of methanol to give 19.5 g of trans-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)aniline.
Smeltepunkt: 76 - 77° CMelting point: 76 - 77° C
Elementæranalyse for C^gl^gNO^:Elemental analysis for C^gl^gNO^:
Beregnet: C 71,44 %, H 9,15 %, N 4,38 %Calculated: C 71.44%, H 9.15%, N 4.38%
Funnet : C 71,87 %, H 9,43 %, N 4,35 Found: C 71.87%, H 9.43%, N 4.35
Eksemp_el_56Example_el_56
Ved å følge den samme prosedyre som beskrevet i eksempel 5.5 under anvendelse av cis-4-(p-menthan-8-yloxy)anilin i stedet for trans-4-(p-menthan-8-yloxy)anilin, ble cis-N-ethoxy-carbonyl-4-(p-menthan-8-yloxy)anilin med krystallisasjonsmethanol erholdt. By following the same procedure as described in Example 5.5 using cis-4-(p-menthan-8-yloxy)aniline instead of trans-4-(p-menthan-8-yloxy)aniline, cis-N -ethoxy-carbonyl-4-(p-menthan-8-yloxy)aniline with crystallization methanol obtained.
Ved tørking av produktet under redusert trykk for å fjerne methanolen ble cis-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)-anilin erholdt som et oljeaktig materiale. On drying the product under reduced pressure to remove the methanol, cis-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)-aniline was obtained as an oily material.
Elementæranalyse for C^gH^NO^:Elemental analysis for C^gH^NO^:
Beregnet: C 71,44%, H 9,1 %, N 4,38 %Calculated: C 71.44%, H 9.1%, N 4.38%
Funnet': C 71,15 %, H'9,37 %, N 4,36 % Found': C 71.15%, H'9.37%, N 4.36%
Kjernemagnetisk resonansspektrium (CDCl-j) (Indre standard TMS) Eksempel 57 , Nuclear Magnetic Resonance Spectrum (CDCl-j) (Internal Standard TMS) Example 57 ,
Til 100 ml vannfri ethanol ble suksessivt tilsatt 2,0 g 4-(p-menthan-8-yloxy) anilin, .1,2 g vannfri kaliumcarbonat og 2,6 g hexadecylbromid (C^^H^^Br) og blandingen ble kokt under tilbake-løpsk jøling i 48 timer. Etter avkjøling av reaksjonsblandingen 2.0 g of 4-(p-menthan-8-yloxy) aniline, 1.2 g of anhydrous potassium carbonate and 2.6 g of hexadecyl bromide (C^^H^^Br) were successively added to 100 ml of anhydrous ethanol and the mixture was cooked under reflux for 48 hours. After cooling the reaction mixture
ble løsningsmidlet destillert fra under rédusert trykk, residuet ble løst i.160 ml diklormethan og 100 ml vann, og diklormethanlaget ble fraskilt. Diklormethanløsningen bie vasket med vann og deretter en vandig natriumkloridløsning og tørket over vannfritt natriumsulfat. Deretter ble løsningsmidlet destillert fra under redusert trykk og det dannede residuum ble overført til en silicagelkolonne. Detønskede produkt ble eluert under anvendelse av the solvent was distilled off under reduced pressure, the residue was dissolved in 160 ml of dichloromethane and 100 ml of water, and the dichloromethane layer was separated. The dichloromethane solution was washed with water and then an aqueous sodium chloride solution and dried over anhydrous sodium sulfate. Then the solvent was distilled off under reduced pressure and the residue formed was transferred to a silica gel column. The desired product was eluted using
benzen mettet med ammoniakk, og løsningsmidlet ble destillert fra eluatet under redusert trykk under dannelse av 1,6 g N-hexa-decyl-4-(p-menthan-8-yloxy)anilin. Ved omkrystallisering av pro- benzene saturated with ammonia, and the solvent was distilled from the eluate under reduced pressure to give 1.6 g of N-hexa-decyl-4-(p-menthan-8-yloxy)aniline. Upon recrystallization of the pro-
duktet fra ethylacétat ble det erholdt hvité krystaller med et smeltepunkt på 42 - 43° C. extracted from ethyl acetate, white crystals with a melting point of 42 - 43° C were obtained.
Elementæranalyse for C32H57^0:Elemental analysis for C32H57^0:
Beregnet: C 81,46 %, H 12,18 %, N 2,97Calculated: C 81.46%, H 12.18%, N 2.97
Funnet : C 81,20 %, H 12,42 %, N 2,69 % Found : C 81.20%, H 12.42%, N 2.69%
Ved lignende prosedyrer som i eksempel 1 ved anvendelse av andre alkoholforbindelser i stedet for p-menthan-8-ol ifølge eksempel, ble det erholdt anilinderivater og disse ble omsatt med hexadecylbromid på lignende i-rjåte som beskrevet i eksempel 57 under dannelse av forbindelsene ifølge eksempel 58 - 61. By similar procedures as in example 1 using other alcohol compounds instead of p-menthan-8-ol according to example, aniline derivatives were obtained and these were reacted with hexadecyl bromide in a similar manner as described in example 57 to form the compounds according to example 58 - 61.
Eksemp_el_58Example_el_58
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
Ønsket forbindelse Desired connection
N-hexadecyl-4-(p-menthan-3-yloxy)anilin N-hexadecyl-4-(p-menthan-3-yloxy)aniline
Smeltepunkt: 43 - 44° C Melting point: 43 - 44° C
Elementæranalyse for C321,57NO:Elemental analysis for C321,57NO:
Beregnet: C 81,46 %, H 12,18 %, N 2,97 %Calculated: C 81.46%, H 12.18%, N 2.97%
Funnet C 81,68 %, H 12,53 %, N 3,13 % Found C 81.68%, H 12.53%, N 3.13%
Eksemp_el_59Example_el_59
Alkoholforbindelse anvendt som utgangsmateriale 1-cyclohexyl-l-methylethanol Ønsket forbindelse Alcohol compound used as starting material 1-cyclohexyl-1-methylethanol Desired compound
4-(1-cyclohexyl-l-methylethoxy)-N^hexadecylanilin Smeltepunkt: 31 - 3 2° C. 4-(1-cyclohexyl-1-methylethoxy)-N^hexadecylaniline Melting point: 31 - 32° C.
Elementæranalyse for C31H55NO:Elemental analysis for C31H55NO:
Beregnet: C 81,32 %, H 12,11 %, N 3,06 % Funnet : C 81,00 %, H.12,65 %, N 3,17 % Calculated: C 81.32%, H 12.11%, N 3.06% Found: C 81.00%, H.12.65%, N 3.17%
Eksemp_el_60Example_el_60
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
1-cyclohexylethanol Ønsket forbindelse 1-cyclohexylethanol Desired compound
4-(1-cyclohexylethoxy)-N-hexadecylanilin Smeltepunkt: 32 - 33° C 4-(1-cyclohexylethoxy)-N-hexadecylaniline Melting point: 32 - 33° C
Elementæranalyse for C^gH^NO:Elemental analysis for C^gH^NO:
Beregnet: C 8o,19 %, H 12,04.%, N 3,16 %Calculated: C 8o.19%, H 12.04%, N 3.16%
Funnet : C 81,15 %, H 12,55 %, ■ N 3,16 % Found : C 81.15%, H 12.55%, ■ N 3.16%
Eksemp_el_61 Example_el_61
Alkoholforbindelse anvendt som utgangsmateriale Alcohol compound used as starting material
1-benzyl-l-methylethanol • 1-benzyl-l-methylethanol •
Ønsket forbindelseDesired connection
N-hexadecyl-4-(a,a-dimethylfenethyloxy)anilin Smeltepunkt: 45 - 46° C N-hexadecyl-4-(a,a-dimethylphenethyloxy)aniline Melting point: 45 - 46° C
Elementæranalyse for ^32H5iN0:Elemental analysis for ^32H5iN0:
Beregnet: C 82,52 %, H 11,04 %, N 3,01 % Calculated: C 82.52%, H 11.04%, N 3.01%
Funnet : C 82,56 H 11, 46 %, N 3,02 % Found : C 82.56 H 11.46%, N 3.02%
Eksempel_62Example_62
I 80 ml vannfri ethanol ble oppløst 2,5 g 4-(p-menthan-. 8-yloxy)anilin og etter tilsetning 2,8 g vannfri kaliumcarbonat, en løsning på 2,8 g methyljodid i 10 ml vannfritt ethanol ble dråpevis tilsatt til blandingen under omrøring ved romtemperatur. Etter koking under tilbakeløpskjøling over natten ble løsnings-midlet destillert fra ved redusert trykk, og residuet ble ekstrahert méd.diklormethan. Ekstraktet ble vasket med vann og deretter en vandig natriumkloridløsning og tørket over vannfritt maghesium-sulfat. Løsningsmidlet ble destillert fra under redusert.trykk og residuet ble ekstrahert med ether, uløselig ammoniumsalter ble fjernet, og etter avdestillering av ether ble det oljeaktige materiale overført til en silicagelkolonne. Deretter.ble det ønskede produkt eluert under anvendelsé av benzen mettet med ammoniakk og løsningsmidlet ble destillert fra eluatet under redusert trykk. Det gjenværende oljeaktige materiale ble løst i 50 ml tørr ether og 1 ml av en blanding av 5 normal saltsyre og ethanol ble til satt til løsningen, hvorved 1,8 g krystallinsk 4-(p-menthan-8-yloxy)-N,N-dimethylanilin-hydroklorid ble erholdt. Ved omkrystallisering av produktet fra en blanding av diklormethan. og .- a ethylacetat ble det erholdt hvite krystaller med et smeltepunkt på 148 -r 149° D. 2.5 g of 4-(p-menthan-.8-yloxy)aniline were dissolved in 80 ml of anhydrous ethanol and after adding 2.8 g of anhydrous potassium carbonate, a solution of 2.8 g of methyl iodide in 10 ml of anhydrous ethanol was added dropwise to the mixture with stirring at room temperature. After boiling under reflux overnight, the solvent was distilled off under reduced pressure, and the residue was extracted with dichloromethane. The extract was washed with water and then an aqueous sodium chloride solution and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and the residue was extracted with ether, insoluble ammonium salts were removed, and after distilling off the ether, the oily material was transferred to a silica gel column. Then, the desired product was eluted using benzene saturated with ammonia and the solvent was distilled from the eluate under reduced pressure. The remaining oily material was dissolved in 50 ml of dry ether and 1 ml of a mixture of 5 normal hydrochloric acid and ethanol was added to the solution, whereby 1.8 g of crystalline 4-(p-menthan-8-yloxy)-N,N -dimethylaniline hydrochloride was obtained. By recrystallization of the product from a mixture of dichloromethane. and .- a ethyl acetate, white crystals with a melting point of 148 -r 149° D were obtained.
Elementæranalyse for C^qH^qNOCI:Elemental analysis for C^qH^qNOCI:
Beregnet: C 69,32 %, H 9,70%, N 4,49 %Calculated: C 69.32%, H 9.70%, N 4.49%
Funnet. : C 69,02 %, H 9,92 %, N 4,51 % Found. : C 69.02%, H 9.92%, N 4.51%
Eksemp_el_6 3Example_el_6 3
En løsning av 580 mg 4-(p-menthan-8-yloxy)acetanilid i 10 ml vannfri tetrahydrofuran ble dråpevis tilsatt under omrøring A solution of 580 mg of 4-(p-menthan-8-yloxy)acetanilide in 10 ml of anhydrous tetrahydrofuran was added dropwise with stirring
til en suspensjon av 100 mg. lithiumaluminiumhydrid i 1 ml vannfri tetrahydrofuran, og blandingen ble kokt under tilbakeløpskjøling i 5 timer. Til reaksjonsblandingen ble suksessivt tilsatt .0,1 ml . vann, 0,1 ml av en vandig 15 %-ig natriumhydroxydløsning og 0,3 ml vann under avkjøling, og etter filtrering av uløselige bestanddeler ble løsninqsmidlet destillert fra under redusert trykk. to a suspension of 100 mg. lithium aluminum hydride in 1 ml of anhydrous tetrahydrofuran, and the mixture was refluxed for 5 hours. 0.1 ml was successively added to the reaction mixture. water, 0.1 ml of an aqueous 15% sodium hydroxide solution and 0.3 ml of water under cooling, and after filtering insoluble constituents, the solvent was distilled from under reduced pressure.
Det dannede residuum ble overført til en silicagelkolonne og det ønskede produkt ble eluert under anvendelse av ammoniakk-mettet benzen. Eluatet ble konsentrert under redusert trykk og destillert under redusert trykk under dannelse av 300 mg N-ethyl-4-(p-menthan-8-yloxy)anilin. The residue formed was transferred to a silica gel column and the desired product was eluted using ammonia-saturated benzene. The eluate was concentrated under reduced pressure and distilled under reduced pressure to give 300 mg of N-ethyl-4-(p-menthan-8-yloxy)aniline.
Smeltepunkt: 143 - 145°C/0,35 mmHgMelting point: 143 - 145°C/0.35 mmHg
Elementæranalyse for C^g<H>^NQ:Elemental analysis for C^g<H>^NQ:
Beregnet: C 78,49 %, H 10,61 %, N 5,09 %Calculated: C 78.49%, H 10.61%, N 5.09%
Funnet : C 78,31 %, H 10,75 %, N 5,41 % Found : C 78.31%, H 10.75%, N 5.41%
Eksempel 64Example 64
I en blanding av 225 ml vannfri pyridin og 450 ml vannfri tetrahydrof uran ble løst 49,5 g 4-(p-menthan-8-yloxy)'-anilin (cis-is.omer: trans-isomer = 45 : 55) og etter dråpevis tilsetning av 48 g ethylklorcarbonat til løsninge.n' under omrøring og isavkjøling, ble blandingen omrørt over natten ved 4° C. Reaks jonsblandingen ble heldt over i 1 liter isvann og ekstrahert med 500 ml ether. Ekstraktet ble vasket suksessivt.med vann, 4 % saltsyre, vann, en vandig natriumhydrogencarbonatløsning og vann, og tørket over vannfritt magnesiumsulfat. Etheren ble destillert fra under redusert trykk, det dannede residuum fikk stå under is-avkjøling, og de dannede, krystaller ble omkrystallisert fra methanol i en mengde på 4 ganger volumet under dannelse av 31 g N-ethoxycarbonyl-4-(p-menthan-8-yloxy)anilin inneholdende en stor del av transisomeren. Krystallene ble omkrystallisert tre ganger fra methanol i en mengde på 2 - 3 ganger volumet.derav, under dannelse av 14,5 g trans-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)-anilin.. In a mixture of 225 ml of anhydrous pyridine and 450 ml of anhydrous tetrahydrofuran, 49.5 g of 4-(p-menthan-8-yloxy)'-aniline (cis-isomer: trans-isomer = 45:55) were dissolved and after the dropwise addition of 48 g of ethyl chlorocarbonate to the solution with stirring and ice-cooling, the mixture was stirred overnight at 4° C. The reaction mixture was poured into 1 liter of ice water and extracted with 500 ml of ether. The extract was washed successively with water, 4% hydrochloric acid, water, an aqueous sodium bicarbonate solution and water, and dried over anhydrous magnesium sulfate. The ether was distilled off under reduced pressure, the residue formed was allowed to stand under ice-cooling, and the crystals formed were recrystallized from methanol in an amount of 4 times the volume to give 31 g of N-ethoxycarbonyl-4-(p-menthan- 8-yloxy)aniline containing a large part of the trans isomer. The crystals were recrystallized three times from methanol in an amount of 2-3 times its volume, forming 14.5 g of trans-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)-aniline.
Smeltepunkt:' 75 - 76° CMelting point:' 75 - 76° C
Renheten av trans-isomeren ble fastslått'til å være 98,9 % ved . kjernemagnetisk resonansspektrum, infrarød absorpr The purity of the trans isomer was determined to be 98.9% at . nuclear magnetic resonance spectrum, infrared absorp
sjonsspektrum, '''H. kjernemagnetisk resonansspektrum og massespektrum til produktet stemte godt overens med disse spektra for det rene materiale. tion spectrum, '''H. nuclear magnetic resonance spectrum and mass spectrum of the product agreed well with these spectra for the pure material.
Eksemp_el_65Example_el_65
Modervæskene som ble dannet ved fremstilling av krystallene av trans-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)-anilin i eksempel 64 ble kombinert med hverandre, methanol ble destillert fra under redusert trykk, og det dannede residuum ble omkrystallisert fire ganger fra methanol i en mengde på 3 ganger volumet derav, under dannelse av 16,2 g methanol-holdige krystaller av cis-N-,ethoxycarbonyl-4-(p-menthan-8-yloxy) anil in. Produktet fikk stå ved redusert trykk for å fjerne methanolen, hvorved oljeaktig cis-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)anilin ble erholdt. The mother liquors formed in the preparation of the crystals of trans-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)-aniline in Example 64 were combined with each other, methanol was distilled off under reduced pressure, and the residue formed was recrystallized four times from methanol in an amount 3 times its volume, forming 16.2 g of methanol-containing crystals of cis-N-,ethoxycarbonyl-4-(p-menthan-8-yloxy)anil in. The product was left under reduced pressure to remove the methanol, whereby oily cis-N-ethoxycarbonyl-4-(p-menthan-8-yloxy)aniline was obtained.
Renheten av cis-isomeren ble fastslått til å være 80 % 13 The purity of the cis isomer was determined to be 80% 13
ved C.kjernemagnetisk resonansspektrum.at C.nuclear magnetic resonance spectrum.
Eksemp_e.l_66 Example_e.l_66
En løsning av 2,57 g 4-(p-menthan-8-yloxy)-N-stearoyl-anilin i 25 ml vannfri tetrahydrofuran ble dråpevis tilsatt til en suspensjon av 0,25 g lithiumaluminiumhydrid i 3 ml vannfri tetrahydrofuran under omrøring og isavkjøling, og blandingen ble kokt under tilbakeløpskjøling i 6 timer. Etter isavkjøling ble reaksjonsblandingen tilsatt 0,3 ml vann, 0,3 ml vandig 15 %-ig natriumhydroxydløsning og deretter 1,0 ml vann under omrøring. Etter ytterligere omrøring av blandingen i ca. 30 minutter ble uløselige bestanddeler filtrert fra, og filtratet ble konsentrert under redusert trykk. Det erholdte konsentrat ble løst i 50 ml ether, og etter vasking av løsningen med en mettet vandig natrium-kloridløsning, ble løsningen tørket over vannfritt natriumsulfat. Deretter ble løsningsmidlet destillert fra ved redusert trykk, og det dannede residuum ble overført til en silicagelkolonne. Det ønskede produkt ble eluert med ammoniakk-mettet benzen, og løs-ningsmidlet ble destillert fra eluatet under redusert trykk under dannelse av 1,49 g krystaller av 4-(p-menthan-8-yloxy)-N-octa-decylanilin. Ved omkrystallisering av produktet fra ethanol ble det erholdt hvite krystaller med et smeltepunkt på 38 - 39° C. A solution of 2.57 g of 4-(p-menthan-8-yloxy)-N-stearoyl-aniline in 25 ml of anhydrous tetrahydrofuran was added dropwise to a suspension of 0.25 g of lithium aluminum hydride in 3 ml of anhydrous tetrahydrofuran with stirring and ice-cooling , and the mixture was refluxed for 6 hours. After ice-cooling, 0.3 ml of water, 0.3 ml of aqueous 15% sodium hydroxide solution and then 1.0 ml of water were added with stirring. After further stirring the mixture for approx. After 30 minutes, insoluble components were filtered off, and the filtrate was concentrated under reduced pressure. The resulting concentrate was dissolved in 50 ml of ether, and after washing the solution with a saturated aqueous sodium chloride solution, the solution was dried over anhydrous sodium sulfate. The solvent was then distilled off under reduced pressure, and the resulting residue was transferred to a silica gel column. The desired product was eluted with ammonia-saturated benzene, and the solvent was distilled from the eluate under reduced pressure to give 1.49 g of crystals of 4-(p-menthan-8-yloxy)-N-octa-decylaniline. On recrystallization of the product from ethanol, white crystals with a melting point of 38 - 39° C were obtained.
Elementæranalyse for C^Hg-^NO:Elemental analysis for C^Hg-^NO:
Beregnet: C 81,70 %, H 12,30 %, N 2,80 %Calculated: C 81.70%, H 12.30%, N 2.80%
Funnet : C 81,49 %, H 12,73 %, N 2,85 % Found : C 81.49%, H 12.73%, N 2.85%
Ved lignende prosedyre som beskrevet i eksempel 66By similar procedure as described in example 66
under anvendelse av forbindelser erholdt i eksempel 27 og 28using compounds obtained in examples 27 and 28
i stedet for 4-(p-menthan-8-yloxy)-N-stearoylanilin i eksempel 66, ble forbindelsene ifølge eksempel 67 og 68 erholdt. instead of 4-(p-menthan-8-yloxy)-N-stearoylaniline in Example 66, the compounds of Examples 67 and 68 were obtained.
Eksemp_el_67Example_el_67
Alkoholforbindelse anvendt som utganqsmateriale 4-(p-menthan-8-yloxy)-N-decanoylanilin Alcohol compound used as starting material 4-(p-menthan-8-yloxy)-N-decanoylaniline
(produkt erholdt i eksempel 27)(product obtained in example 27)
Ønsket forbindelseDesired connection
N-decyl-4-(p-menthan-8-yloxy)anilin Kokepunkt: 172 - 175°C/0,2 mmHg Elementæranalyse for C2gH4t.NO: Beregnet: C 80,56 %, H 11,70 i, N 3,61 * Funnet : C. 80,35 %, H 12 , 06 N 3,67 % N-decyl-4-(p-menthan-8-yloxy)aniline Boiling point: 172 - 175°C/0.2 mmHg Elemental analysis for C2gH4t.NO: Calculated: C 80.56 %, H 11.70 i, N 3 ,61 * Found : C. 80.35%, H 12 , 06 N 3.67%
Eksemp_el_68 Example_el_68
Alkoholforbindelse anvendt som utgangsmateriale 4-(p-menthan-8-yloxy)-N-myristoylanilin Alcohol compound used as starting material 4-(p-menthan-8-yloxy)-N-myristoylaniline
(produkt erholdt i eksempel 28)(product obtained in example 28)
Ønsket forbindelseDesired connection
4-(p-menthan-8-yloxy)-N-tetradecylanilin Smeltepunkt: 195 - 200°C/0,25 mmHg Elementæranalyse for C^qH^^NO: Beregnet: C 81,20 % , H 12,04 %, N 3 ,16 % Funnet : C 8.1,01%, H 12,40 %, N 3,17 % 4-(p-menthan-8-yloxy)-N-tetradecylaniline Melting point: 195 - 200°C/0.25 mmHg Elemental analysis for C^qH^^NO: Calculated: C 81.20% , H 12.04%, N 3.16% Found : C 8.1.01%, H 12.40%, N 3.17%
Eksempel 69Example 69
I 20 ml vannfri ethanol ble oppløst 1 g 4-(p-menthan-8-yloxy)acetanilid, og etter tilsetning av 0,4 g kalium-tertiær butoxyd og 0/6 g benzylbromid, ble blandingen omrørt i 2 4 timer ved romtemperatur. Løsningsmidlet ble destillert fra under redusert trykk, og residuet ble behandlet med diklormethan og "vann. In 20 ml of anhydrous ethanol, 1 g of 4-(p-menthan-8-yloxy)acetanilide was dissolved, and after the addition of 0.4 g of potassium tertiary butoxide and 0/6 g of benzyl bromide, the mixture was stirred for 24 hours at room temperature . The solvent was distilled off under reduced pressure and the residue was treated with dichloromethane and water.
Det dannede diklormethanlag ble fraskilt, vasket med vann og deretter med en vandig natriumkloridløsning og tørket over vannfritt magnesiumsulfat. Løsningsmidlet ble destillert fra under redusert trykk, og det erholdte oljeaktige materiale ble overført til en silicagelkolonne. Detønskede produkt ble eluert med ammonia.kk-mettet benzen, løsningsmidlet ble destillert fra eluatet ved redusert trykk, og det syrupaktige materiale ble destillert under redusert trykk under dannelse av 1,15 g N-benzyl-4-(p-menthan-8-yloxy) acetanilid... The formed dichloromethane layer was separated, washed with water and then with an aqueous sodium chloride solution and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and the resulting oily material was transferred to a silica gel column. The desired product was eluted with ammonia-saturated benzene, the solvent was distilled from the eluate under reduced pressure, and the syrupy material was distilled under reduced pressure to give 1.15 g of N-benzyl-4-(p-menthan-8- yloxy) acetanilide...
Kokepunkt: 195 - 200°C/0,6 mmHgBoiling point: 195 - 200°C/0.6 mmHg
Elementæranalyse for C25H33NO2:Elemental analysis for C25H33NO2:
Beregnet: C 79,11 I, H 8,76 I, N 3", 69 % Funnet : C 79,49 %, H 8,96 %, N 3,94 % Calculated: C 79.11 I, H 8.76 I, N 3", 69% Found : C 79.49%, H 8.96%, N 3.94%
Eksemgel_70Eczema gel_70
1 1
I 20 ml vannfri ethanol ble oppløst 750 mg N-cinnamoyl-4-(p-menthan-8-yloxy)anilin erholdt i eksempel 21, og etter tilsetning av 350 mg 10 %-ig palladiumcarbon, ble nlandingen omrørt i en hydrogenatmosfære inntil en teoretisk mengde hydrogen var blitt absorbert. Etter filtrering av palladiumcarbon, ble løs-ningsmidlet destillert under redusert trykk og det dannede residuum ble omkrystallisert fra 85 %-ig ethanol under dannelse av 0,7 g hvitt krystallinsk. 4-(p-menthan-8-yloxy)-N-(3-fenylpropio-nyDanilin. 750 mg of N-cinnamoyl-4-(p-menthan-8-yloxy)aniline obtained in example 21 were dissolved in 20 ml of anhydrous ethanol, and after the addition of 350 mg of 10% palladium carbon, the mixture was stirred in a hydrogen atmosphere until a theoretical amount of hydrogen had been absorbed. After filtration of palladium carbon, the solvent was distilled under reduced pressure and the residue formed was recrystallized from 85% ethanol to form 0.7 g of white crystalline. 4-(p-Menthan-8-yloxy)-N-(3-phenylpropionylDaniline).
Smeltepunkt: 96 - 97° CMelting point: 96 - 97° C
Elementæranalyse for C25H33N02:Elemental analysis for C25H33N02:
Beregnet: C.79,11 %, H 8,76 %, N 3,69 %Calculated: C.79.11%, H 8.76%, N 3.69%
Funnet : C 78,99 %, H 8,91 %, N 3,68 % Found : C 78.99%, H 8.91%, N 3.68%
Eksempel_71 Example_71
En løsning'av 3,2 g N-ethoxycarbonyl-4-(p-menthan-8-yloxy)anilin i 60 ml vannfri tetrahydrofuran ble dråpevis tilsatt til en suspensjon av 0,5 g lithiumaluminiumhydrid i 6 ml vannfri. tetrahydrofuran under omrøring i løpet av 2 timer, og blandingen ble deretter kokt under tilbakeløpskjøling i 5 timer. Etter is-avkjøling av reaksjonsblandingen ble 0,6 ml vann, 1 ml av en vandig 15 %-ig natriumhydroxydløsning og deretter 2 ml vann tuk-sessivt tilsatt blandingen. Etter filtrering av uløselige bestanddeler ble løsningsmidlet destillert fra under redusert trykk, og residuet ble ekstrahert med ether. Ekstraktet ble vasket med vann,.tørket over vannfritt magnesiumsulfat og løsningsmidlet ble deretter destillert fra under redusert trykk. Residuet ble over-ført til en silicagel-kolonne og det ønskede produkt ble eluert under anvendelse av ammoniakk-mettet benzen. Løsningsmidlet i eluatet ble fordampet under redusert trykk, og det gjenværende oljeaktige produkt ble destillert under redusert trykk under dannelse av 1,22 g 4-(p-menthan-8-yloxy)-N-methylanilin. A solution of 3.2 g of N-ethoxycarbonyl-4-(p-menthan-8-yloxy)aniline in 60 ml of anhydrous tetrahydrofuran was added dropwise to a suspension of 0.5 g of lithium aluminum hydride in 6 ml of anhydrous. tetrahydrofuran with stirring over 2 hours, and the mixture was then refluxed for 5 hours. After ice-cooling the reaction mixture, 0.6 ml of water, 1 ml of an aqueous 15% sodium hydroxide solution and then 2 ml of water were successively added to the mixture. After filtration of insolubles, the solvent was distilled off under reduced pressure, and the residue was extracted with ether. The extract was washed with water, dried over anhydrous magnesium sulfate and the solvent was then distilled off under reduced pressure. The residue was transferred to a silica gel column and the desired product was eluted using ammonia-saturated benzene. The solvent in the eluate was evaporated under reduced pressure, and the remaining oily product was distilled under reduced pressure to give 1.22 g of 4-(p-menthan-8-yloxy)-N-methylaniline.
Kokepunkt: 14 8 - 151°C/0,6 mm HgBoiling point: 14 8 - 151°C/0.6 mm Hg
Elementæranalyse for C^I-^^NO:Elemental analysis for C^I-^^NO:
Beregnet: C 78,11 %, H 10,41 %, N 5,36 %Calculated: C 78.11%, H 10.41%, N 5.36%
Funnet : C 78,08 %, H 10,80 %, N 5,51 % Found : C 78.08%, H 10.80%, N 5.51%
Eksemp_el_72Example_el_72
1.5 ml vannfri tetrahydrofuran ble oppløst 430 mg N-methyl-4-(p-menthan-8-yloxy)anilin, og etter tilsetning av .300 mg eddiksyreanhydrid og 0,8 ml vannfri pyridin, ble den resulterende blanding omrørt over natten ved romtemperatur. Reaksjonsblandin-. gen ble heldt over 30 ml isvann og de erholdte krystaller ble omkrystallisert fra 5 ml petroleumether under dannelse av 350 mg 1.5 ml of anhydrous tetrahydrofuran was dissolved in 430 mg of N-methyl-4-(p-menthan-8-yloxy)aniline, and after addition of .300 mg of acetic anhydride and 0.8 ml of anhydrous pyridine, the resulting mixture was stirred overnight at room temperature . Reaction mixture-. was poured over 30 ml of ice water and the crystals obtained were recrystallized from 5 ml of petroleum ether to form 350 mg
hvitt krystallinsk 4-(p-menthan-8-yloxy)-N-methylacetanilid.white crystalline 4-(p-menthan-8-yloxy)-N-methylacetanilide.
■ i. ■ i.
Smeltepunkt: 70 - 71° C Elementæranalyse for C-^gl^.gNC^: '.' Melting point: 70 - 71° C Elemental analysis for C-^gl^.gNC^: '.'
Beregnet: C.75,21%, H 9,63 %, N 4,62 %Calculated: C.75.21%, H 9.63%, N 4.62%
Funnet : C 75,01 %, H 9,96 %, N 4 , 41 % Found : C 75.01%, H 9.96%, N 4 , 41%
Eksempel_73Example_73
I 30 ml vannfri ethanol ble oppløst 1 g 4-(p-menthan-8-yloxy)-N,N-dimethylanilin som var befridd for dens hydroklorid ifølge eksempel 62, og etter tilsetning av 5 ml methyljodid, ble' blandingen kokt under tilbakeløpskjøling over natten. Løsnings-midlet og overskudd methyljodid ble destillert fra under redusert In 30 ml of anhydrous ethanol was dissolved 1 g of 4-(p-menthan-8-yloxy)-N,N-dimethylaniline which had been freed from its hydrochloride according to Example 62, and after addition of 5 ml of methyl iodide, the mixture was boiled under reflux over the night. The solvent and excess methyl iodide were distilled from under reduced
trykk,, og det dannede residuum ble ekstrahert med diklormethan. Ekstraktet ble vasket med vann og deretter en vandig natrium-kloridløsning og tørket over vannfritt magnesiumsulfat. Løsnin-gen ble konsentrert under redusert trykk, overskudd ether ble tilsatt til konsentratet og det dannede bunnfall ble oppsamlet ved filtrering og omkrystallisert fra en blanding av diklormethan og ether under dannelse av 0,9 g hvitt krystallinsk 4-(p-menthan-8-• yloxy)-N,N,N-trimethylaniliniumjorid. pressure, and the residue formed was extracted with dichloromethane. The extract was washed with water and then an aqueous sodium chloride solution and dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, excess ether was added to the concentrate and the precipitate formed was collected by filtration and recrystallized from a mixture of dichloromethane and ether to give 0.9 g of white crystalline 4-(p-menthan-8- • yloxy)-N,N,N-trimethylanilinium iodide.
Smeltepunkt: 179 - 180° CMelting point: 179 - 180° C
Elementæranalyse for C^gH-^NOI:Elemental analysis for C^gH-^NOI:
Beregnet: C 54,68 %, H 7,73 %, N 3,36 %Calculated: C 54.68%, H 7.73%, N 3.36%
Funnet : C 54,34 %, H 7,91 %, N 3,25 % Found : C 54.34%, H 7.91%, N 3.25%
Eksemp_el_74Example_el_74
I en løsning av 1,6 g nicotinsyre og 1,31 g triethyl-amin i 30 ml methylenklorid ble dråpevis tilsatt 1,4 g ethylklorcarbonat under omrøring og avkjøling. Til den dannede løs- ning ble dråpevis tilsatt en løsning av .2,5 g cis-4-(p-menthan-8-yloxy)anilin i 20 ml methylenklorid. Etter omrøring av blandingen for å bevirke reaksjon i 30 minutter ved samme temperatur, .i, ble reaksjonsblandingen heldt over i isvann. Det dannede orga-niske lag ble vasket suksessivt med vandig 5 %-ig natriumcarbonat-løsning og vandig mettet natriumkloridløsning, og tørket over vannfritt natriumsulfat. Løsningsmidlet ble destillert fra ved redusert trykk og det dannede residuum ble overført til en silicagelkolonne. Det ønskede produkt ble eluert under anvendelse av kloroform og løsningsmidlet ble destillert fra eluatet. Når residuet ble omkrystallisert fra ethanol ble det erholdt 2,3 g In a solution of 1.6 g of nicotinic acid and 1.31 g of triethylamine in 30 ml of methylene chloride, 1.4 g of ethyl chlorocarbonate was added dropwise while stirring and cooling. A solution of 2.5 g of cis-4-(p-menthan-8-yloxy)aniline in 20 ml of methylene chloride was added dropwise to the resulting solution. After stirring the mixture to cause reaction for 30 minutes at the same temperature, the reaction mixture was poured into ice water. The organic layer formed was washed successively with aqueous 5% sodium carbonate solution and aqueous saturated sodium chloride solution, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure and the residue formed was transferred to a silica gel column. The desired product was eluted using chloroform and the solvent was distilled from the eluate. When the residue was recrystallized from ethanol, 2.3 g were obtained
hvite krystaller av cis-4-(p-menthan-8-yloxy)-N-nicotinoylanilin. white crystals of cis-4-(p-menthan-8-yloxy)-N-nicotinoylaniline.
Smeltepunkt: 122 - 123° CMelting point: 122 - 123° C
Elementæranalyse for (-:22H28N2(*l2:Elemental analysis for (-:22H28N2(*l2:
Beregnet: C 74,96 %, H 8,01 %, N 7,95 %Calculated: C 74.96%, H 8.01%, N 7.95%
Funnet : C 74,53 %, H 7,98 %, N 7,99 % Found : C 74.53%, H 7.98%, N 7.99%
Eksempel 75Example 75
TabletterPills
1000 tabletter for oral bruk, hver inneholdende 100 mg , ,1-[4-(p-menthan-8-yloxy)fenyl]piperidin, ble fremstilt fra føl-gende bestanddeler: 1000 tablets for oral use, each containing 100 mg, ,1-[4-(p-menthan-8-yloxy)phenyl]piperidine, were prepared from the following ingredients:
1-[4-(p-menthan-8-yloxy)fenyl]piperidin: 100 g1-[4-(p-Menthan-8-yloxy)phenyl]piperidine: 100 g
Methylcellulose J.P.: 6,5 gMethyl cellulose J.P.: 6.5 g
Lactose: 25 gLactose: 25 g
Talkum: 5 gTalc: 5 g
Calciumstearat: 3,5 gCalcium stearate: 3.5 g
1-[4-(p-menthan-8-yloxy)fenyl]piperidin ble granulert,1-[4-(p-menthan-8-yloxy)phenyl]piperidine was granulated,
med 7,5 g % W/v vandig løsning av methylcellulose, ført gjennom en sikt nr. 8 og tørket1 omhyggelig-. De tørrede granuler ble ført gjennom en sikt nr. 12, blandet med talkum/ lactose og stearat og presset til tabletter... with 7.5 g% w/v aqueous solution of methylcellulose, passed through a No. 8 sieve and dried1 carefully-. The dried granules were passed through a No. 12 sieve, mixed with talc/lactose and stearate and pressed into tablets...
Claims (1)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15809977A JPS5492926A (en) | 1977-12-29 | 1977-12-29 | Compound of aminophenyl ether and its preparation |
| JP3462478A JPS54128535A (en) | 1978-03-25 | 1978-03-25 | Aminophenyl ether compound and its preparation |
| JP9129278A JPS5519217A (en) | 1978-07-26 | 1978-07-26 | Aminophenyl ether derivative and its preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO820355L true NO820355L (en) | 1979-07-02 |
Family
ID=27288474
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO784394A NO784394L (en) | 1977-12-29 | 1978-12-28 | PROCEDURES FOR THE PREPARATION OF AMINOPHENYL ETHER COMPOUNDS |
| NO820355A NO820355L (en) | 1977-12-29 | 1982-02-05 | PROCEDURES FOR THE PREPARATION OF CYCLIC AMINOPHENYL ETHER COMPOUNDS. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO784394A NO784394L (en) | 1977-12-29 | 1978-12-28 | PROCEDURES FOR THE PREPARATION OF AMINOPHENYL ETHER COMPOUNDS |
Country Status (12)
| Country | Link |
|---|---|
| AT (1) | AT367738B (en) |
| AU (1) | AU4301778A (en) |
| CA (1) | CA1110248A (en) |
| DE (1) | DE2854595A1 (en) |
| DK (1) | DK584978A (en) |
| ES (3) | ES476458A1 (en) |
| FR (1) | FR2413382A1 (en) |
| GB (1) | GB2011888B (en) |
| IT (1) | IT7869973A0 (en) |
| NL (1) | NL7812574A (en) |
| NO (2) | NO784394L (en) |
| SE (1) | SE7813355L (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4261651A (en) * | 1978-05-31 | 1981-04-14 | The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | Liquid crystal compounds |
| DE2948056A1 (en) * | 1979-11-29 | 1981-06-04 | Boehringer Mannheim Gmbh, 6800 Mannheim | NEW AMINOPROPANOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
| DE3903989A1 (en) * | 1989-02-10 | 1990-09-20 | Basf Ag | DIPHENYLHETEROALKYL DERIVATIVES, THEIR PREPARATION, AND MEDICAMENTS AND COSMETICS THEREOF |
| US5527945A (en) * | 1989-02-10 | 1996-06-18 | Basf Aktiengesellschaft | Diphenylheteroalkyl derivatives, the preparation thereof and drugs and cosmetics prepared therefrom |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1793030A (en) * | 1930-03-01 | 1931-02-17 | Thorp Lambert | Isopropyl ether of para-acetyl amino phenol |
| GB1093121A (en) * | 1963-05-31 | 1967-11-29 | Wellcome Found | Etherified ªÐ-hydroxyanilines |
-
1978
- 1978-12-15 GB GB7848658A patent/GB2011888B/en not_active Expired
- 1978-12-18 CA CA318,098A patent/CA1110248A/en not_active Expired
- 1978-12-18 DE DE19782854595 patent/DE2854595A1/en not_active Ceased
- 1978-12-22 FR FR7836263A patent/FR2413382A1/en not_active Withdrawn
- 1978-12-27 NL NL7812574A patent/NL7812574A/en not_active Application Discontinuation
- 1978-12-28 SE SE7813355A patent/SE7813355L/en unknown
- 1978-12-28 DK DK584978A patent/DK584978A/en unknown
- 1978-12-28 ES ES476458A patent/ES476458A1/en not_active Expired
- 1978-12-28 NO NO784394A patent/NO784394L/en unknown
- 1978-12-28 IT IT7869973A patent/IT7869973A0/en unknown
- 1978-12-29 AU AU43017/78A patent/AU4301778A/en active Pending
- 1978-12-29 AT AT0935778A patent/AT367738B/en not_active IP Right Cessation
-
1979
- 1979-06-12 ES ES481505A patent/ES481505A1/en not_active Expired
- 1979-06-12 ES ES481504A patent/ES481504A1/en not_active Expired
-
1982
- 1982-02-05 NO NO820355A patent/NO820355L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU4301778A (en) | 1979-07-05 |
| DE2854595A1 (en) | 1979-07-12 |
| IT7869973A0 (en) | 1978-12-28 |
| DK584978A (en) | 1979-06-30 |
| ATA935778A (en) | 1981-12-15 |
| ES481505A1 (en) | 1980-04-01 |
| GB2011888A (en) | 1979-07-18 |
| CA1110248A (en) | 1981-10-06 |
| ES481504A1 (en) | 1980-04-01 |
| SE7813355L (en) | 1979-06-30 |
| NO784394L (en) | 1979-07-02 |
| AT367738B (en) | 1982-07-26 |
| ES476458A1 (en) | 1979-11-16 |
| GB2011888B (en) | 1982-09-22 |
| FR2413382A1 (en) | 1979-07-27 |
| NL7812574A (en) | 1979-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4959366A (en) | Anti-arrhythmic agents | |
| NO144262B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE N-SUBSTITUTED BENZAMIDE DERIVATIVES | |
| NO158419B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,2-DIAMINOCYCLOBUTEN-3,4-DIONES. | |
| DE19933926A1 (en) | Biphenyl derivatives, their preparation and their use as medicines | |
| DE2824064A1 (en) | PHTHALAZINE DERIVATIVES, THEIR PRODUCTION AND SUCH DERIVATIVES MEDICINAL PRODUCTS | |
| EP0429685A1 (en) | Oxoindole derivative | |
| US4466964A (en) | Lipid absorption-inhibiting 1,4-benzothiazines | |
| US4207327A (en) | N-(4-Pyrazolidinyl)benzamides and their amino precursors | |
| JPS61100563A (en) | 1-((aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-alpha,alpha-diarylpyrrolidine, piperidine and homopiperidine acetamide and acetonitrile | |
| JPH0283375A (en) | 2-substituted piperazinyl-2-(1,2-benzisoxazol-3-yl)acetic acid derivative | |
| DK164155B (en) | AMINOGUANIDE DERIVATIVES AND PHARMACEUTICAL TOLERABLE SALTS THEREOF, PROCEDURES FOR PREPARING THEREOF, PHARMACEUTICALS CONTAINING AMINOGUANIDE DERIVATIVES AND PROCEDURES FOR THE PREPARATION OF THESE MEDICINES | |
| JP3877762B2 (en) | Novel hydroxymic acid derivatives, pharmaceutical compositions containing them and methods for producing the same | |
| NO820355L (en) | PROCEDURES FOR THE PREPARATION OF CYCLIC AMINOPHENYL ETHER COMPOUNDS. | |
| HU181147B (en) | Process for preparing substituted heterocyclin phenoxamines | |
| US4547514A (en) | Aryloxy-N-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activity | |
| US4397855A (en) | 4-(Substituted)-α, α-dimethyl-1-piperazine pentanoic acids and derivatives as anti-arteriosclerotic agents and method | |
| US4442102A (en) | 1,5-Diphenylpyrazolin-3-one compounds, process and intermediates for preparation thereof and pharmaceutical compositions containing same | |
| US4005209A (en) | Antiarrhythmic method utilizing fluoroalkoxy-N-piperidyl and pyridyl benzamides | |
| US4474783A (en) | Cyclopropylmethyl piperazines, the process for preparing the same and their use in therapeutics | |
| EP0123700A1 (en) | Substituted picolinic acids, processes for their preparation, their use, and pharmaceutical preparations containing them | |
| US5922879A (en) | N-aminoalkyl-2-anthraquinonecarboxamides: new dopamine receptor subtype specific ligands | |
| EP0300371A1 (en) | Hydrocinnamic acid derivatives | |
| WO1991009030A1 (en) | 2-substituted 4,5-diphenyl-imidazoles | |
| US4013670A (en) | Derivatives of pyrrolidine and piperidine | |
| US4511566A (en) | 2-N-Cycloalkylmethyl 3-oxo 5,6-diaryl-as-triazines |